Recurrent or chronic depression

F5_DEPRESSION_RECURRENT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions not (F5_SCHIZO or F5_SCHIZOAFF or F5_BIPO	496819
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — F33 Hospital discharge: ICD-10 — F33 Cause of death: ICD-10 — F33 3 out of 7 registries used, show all original rules.	29709
4. Check minimum number of events None	29709
5. Include endpoints None	29709
6. Filter based on genotype QC (FinnGen only)	28545

Control definitions (FinnGen only)

Control exclude: F5_PSYCH_INCLAVO, ANTIDEPRESSANTS

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF10

NAME	F5_DEPRESSION_RECURRENT
CONTROL_EXCLUDE	F5_PSYCH_INCLAVO\|ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!(F5_SCHIZO\|F5_SCHIZOAFF\|F5_BIPO)
OUTPAT_ICD	F33
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F33
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F33
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Recurrent or chronic depression based on the number of shared cases.

Similar with more cases:

Depression or dysthymia

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	28545	21444	7101
Unadjusted period prevalence (%)	6.52	7.61	3.25
Median age at first event (years)	43.64	42.24	47.89

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
24934: Matched controls
175288

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K30

ICD-10 Finland

Functional dyspepsia

2.4

322.4

2634

8199

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

+∞

322.1

355

J01EA01

ATC

trimethoprim; systemic

1.9

321.5

5462

22591

M01AB05

ATC

diclofenac; systemic, rectal

1.7

319.4

15468

86050

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.7

317.3

13432

72051

SPAT1260

SPAT

Consultation of another employee

2.1

316.9

3718

13471

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

14.0

315.5

361

184

SPAT1312

SPAT

General health counselling

1.8

315.2

7318

33312

Z02.7

ICD-10 Finland

Issue of medical certificate

3.0

314.7

1604

3904

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

313.1

2979

9911

T74.1

ICD-10 Finland

Physical abuse

7.0

312.4

563

577

G47.9

ICD-10 Finland

Sleep disorder, unspecified

5.5

310.7

696

904

P81

ICPC

Hyperkinetic disorder

46.8

310.3

244

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

310.2

7607

35147

G43.3

ICD-10 Finland

Complicated migraine

7.3

309.4

538

528

R51

ICD-10 Finland

Headache

3.2

309.1

1453

3368

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.5

308.0

1214

2510

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2387.3

307.8

342

SFA20

NOMESCO Finland

Two-surface restoration

1.8

307.7

14932

78933

P99

ICPC

Psychological disorders other

51.4

307.7

1071

153

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

9.0

307.7

569

452

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

11.6

307.7

508

315

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

+∞

307.7

6346

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

+∞

307.7

1431

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

307.7

4412

13958

N05AB03

ATC

perphenazine; systemic, rectal

108.8

307.7

838

IBA01, ,

SPAT

18.9

307.7

353

133

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

307.7

13729

65643

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

307.7

6576

26741

F43.29

ICD-10 Finland

Adaptation disorder UNS

+∞

307.7

827

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.5

307.7

3034

9295

SPAT1215

SPAT

Assessment of need for medical rehabilitation

6.2

307.7

1175

1391

A04

ICPC

Weakness/tiredness general

4.2

307.7

4135

7942

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.4

307.7

2006

2376

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

+∞

307.7

529

F39

ICD-10 Finland

Unspecified mood [affective] disorder

+∞

307.7

779

F43.2

ICD-10 Finland

Adjustment disorders

+∞

307.7

499

N06AX22

ATC

agomelatine; oral

428.0

307.7

2015

P58

ICPC

Psychological, Therapeutic counselling/listening

18.4

307.7

871

344

P01

ICPC

Feeling anxious/nervous/tense

21.7

307.7

7036

3116

N89

ICPC

Migraine

4.9

307.7

1181

1762

AA400

NOMESCO Finland

Electroconvulsive therapy

1585.9

307.7

457

N02BF01

ATC

gabapentin; oral

3.4

307.7

1923

4183

L12

ICPC

Hand/finger symptom/complaint

2.1

307.7

3757

13537

N05AF01

ATC

flupentixol; systemic

42.5

307.7

498

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

307.7

7157

28108

N01

ICPC

Headache

3.2

307.7

3454

8313

IHZ05, ,

SPAT

19.1

307.7

1826

724

A02BA02

ATC

ranitidine; systemic

2.2

307.7

3604

12421

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.7

307.7

2137

5905

WZA10, ,

SPAT

49.7

307.7

574

F90.0

ICD-10 Finland

Disturbance of activity and attention

+∞

307.7

2045

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.4

307.7

2876

8978

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

840.3

307.7

1249

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

307.7

4173

14616

Z08

ICPC

Social welfare problem

21.9

307.7

481

157

SAA01

NOMESCO Finland

Simple examination of mouth

2.3

307.7

18943

101085

M25.5

ICD-10 Finland

Pain in joint

2.1

307.7

8117

32920

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

+∞

307.7

7392

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.4

307.7

1360

2294

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

+∞

307.7

2203

OAB93, ,

SPAT

6.5

307.7

2447

2881

P02

ICPC

Acute stress reaction

8.5

307.7

1874

1657

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

13.4

307.7

1589

889

R52.2

ICD-10 Finland

Other chronic pain

6.1

307.7

974

1160

P29

ICPC

Psychological sympt/compl other

20.8

307.7

3410

1326

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

307.7

428

ZYC01

NOMESCO Finland

Remote contact by phone

4.2

307.7

1733

3070

F10.09

ICD-10 Finland

Alcohol intoxication UNS

+∞

307.7

637

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

+∞

307.7

7722

SPAT1238

SPAT

Brief therapy

20.8

307.7

802

279

N06AX12

ATC

bupropion; oral

230.2

307.7

7157

306

H03AA01

ATC

levothyroxine sodium; systemic

2.3

307.7

5626

20013

N05AB01

ATC

dixyrazine; systemic

43.3

307.7

304

M01AE02

ATC

naproxen; oral, rectal

1.9

307.7

14059

71715

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2623.6

307.7

1438

P76

ICPC

Depressive disorder

237.8

307.7

6091

238

N06AA22, ,

ATC

88.5

307.7

237

SPAT1301

SPAT

No procedures

1.9

307.7

6615

27483

N06AB03

ATC

fluoxetine; oral

49.0

307.7

6680

1300

EBA00

NOMESCO Finland

Extraction of tooth

1.8

307.7

8471

39050

S06.0

ICD-10 Finland

Concussion

2.9

307.7

2570

6594

N06AX21

ATC

duloxetine; oral

41.1

307.7

7055

1666

F41.8

ICD-10 Finland

Other specified anxiety disorders

+∞

307.7

1611

H02AB06

ATC

prednisolone; systemic

1.8

307.7

10436

50862

SPAT1283

SPAT

Restricted health certificate

2.5

307.7

5677

18243

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

+∞

307.7

715

F41.00

ICD-10 Finland

Moderate panic disorder

+∞

307.7

848

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

307.7

10442

46201

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.2

307.7

2081

4901

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

+∞

307.7

749

M79.6

ICD-10 Finland

Pain in limb

2.2

307.7

10119

42101

G44.2

ICD-10 Finland

Tension-type headache

3.3

307.7

3973

9429

P01AB01

ATC

metronidazole; oral, rectal

2.0

307.7

9727

43174

Z71.8

ICD-10 Finland

Other specified counselling

2.3

307.7

8079

30454

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

+∞

307.7

2154

N03AE01

ATC

clonazepam; systemic

10.5

307.7

1790

1279

WX110

NOMESCO Finland

Infiltration anesthesia

2.2

307.7

18271

97600

J01DB01

ATC

cefalexin; oral

1.9

307.7

20019

119266

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

+∞

307.7

407

XA800

NOMESCO Finland

Neuropsychological investigation

4.7

307.7

1132

1750

IGY99, ,

SPAT

13.4

307.7

547

294

N06BA04

ATC

methylphenidate; oral

114.3

307.7

1825

121

SPAT1310

SPAT

Counselling related to known health issue

2.0

307.7

7269

30181

IGY02

NOMESCO Finland

Psychiatric monitoring contact

186.3

307.7

1448

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

14058

64718

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

307.7

9179

41625

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

+∞

307.7

459

SPAT1243

SPAT

Psychiatric/psychological examination

50.0

307.7

1493

223

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

307.7

408

N03AX16

ATC

[U] pregabalin

4.1

307.7

6944

14923

E66.01

ICD-10 Finland

Obesity due to excess calories

3.4

307.7

2788

6318

M79.0

ICD-10 Finland

Rheumatism, unspecified

9.5

307.7

1140

881

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

+∞

307.7

661

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

307.7

9732

47574

G43

ICD-10 Finland

Migraine

3.2

307.7

1518

3437

N06AB06

ATC

sertraline; oral

112.0

307.7

7398

658

F32.8

ICD-10 Finland

Other depressive episodes

+∞

307.7

886

V03AA01, ,

ATC

24.6

307.7

390

113

OAB38, ,

SPAT

11.0

307.7

681

446

SAA02

NOMESCO Finland

Basic examination of mouth

2.0

307.7

17526

95244

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

9.8

307.7

515

378

F32.1

ICD-10 Finland

Moderate depressive episode

+∞

307.7

4444

A01

ICPC

Pain general/multiple sites

3.7

307.7

2260

4546

N05CF02

ATC

zolpidem; oral

7.1

307.7

6322

8011

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

307.7

3022

9936

F41.1

ICD-10 Finland

Generalized anxiety disorder

+∞

307.7

4094

F43.1

ICD-10 Finland

Post-traumatic stress disorder

+∞

307.7

1576

N05AH04

ATC

quetiapine; oral

89.9

307.7

10797

1476

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

307.7

6458

22018

N06AG02

ATC

moclobemide; oral

73.3

307.7

2250

237

P15

ICPC

Chronic alcohol abuse

36.6

307.7

1020

204

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

102.1

307.7

1757

130

F43.8

ICD-10 Finland

Other reactions to severe stress

+∞

307.7

882

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

307.7

12019

56668

A02BC02

ATC

pantoprazole; systemic

2.4

307.7

16373

77378

D01

ICPC

Abdominal pain/cramps general

2.8

307.7

3180

8672

L02

ICPC

Back symptom/complaint

2.8

307.7

2625

7086

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

269.9

307.7

960

F10.24

ICD-10 Finland

Alcohol depence active use

+∞

307.7

512

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

1355

Z2446

NOMESCO Finland

Social worker

7.1

307.7

2200

2348

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

1001.6

307.7

954

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.7

307.7

2853

8126

L28

ICPC

Limited function/disability (L)

2.7

307.7

3171

8972

T36

ICD-10 Finland

Poisoning by systemic antibiotics

71.5

307.7

2276

246

G43.9

ICD-10 Finland

Migraine, unspecified

4.3

307.7

2042

3547

F50.9

ICD-10 Finland

Eating disorder, unspecified

+∞

307.7

444

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

5808.4

307.7

807

F32.9

ICD-10 Finland

Depressive episode, unspecified

+∞

307.7

10775

Z3231

NOMESCO Finland

Registered nurse

2.5

307.7

6709

22405

N03AX11

ATC

topiramate; oral

9.0

307.7

815

658

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

307.7

693

N06AX11

ATC

mirtazapine; oral

33.6

307.7

15827

8626

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

307.7

815

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.3

307.7

1633

3664

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

307.7

7859

31192

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

+∞

307.7

5384

P20

ICPC

Memory disturbance

4.2

307.7

1594

2794

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

340.5

307.7

2046

N06AA10

ATC

nortriptyline; systemic

13.2

307.7

682

374

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.9

307.7

2376

6161

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

27.7

307.7

334

Z05

ICPC

Work problem

7.3

307.7

954

952

N02BF02

ATC

pregabalin; oral

5.7

307.7

1848

2443

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

+∞

307.7

802

R53

ICD-10 Finland

Malaise and fatigue

4.3

307.7

6985

14662

N06BA12

ATC

lisdexamfetamine; oral

577.6

307.7

484

F10.25

ICD-10 Finland

Alcohol dependence continuous use

+∞

307.7

523

N06CA01

ATC

amitriptyline and psycholeptics; systemic

7.6

307.7

3273

3434

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

+∞

307.7

3993

N02BE01

ATC

paracetamol; systemic, rectal

2.5

307.7

21588

125952

N06DX01

ATC

memantine; oral

39.9

307.7

303

C07AA05

ATC

propranolol; systemic

5.3

307.7

7188

12449

F34.1

ICD-10 Finland

Dysthymia

+∞

307.7

3609

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

461.3

307.7

515

F33.8

ICD-10 Finland

Other recurrent depressive disorders

+∞

307.7

991

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

+∞

307.7

565

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

307.7

508

F41

ICD-10 Finland

Other anxiety disorders

+∞

307.7

675

J02AC01

ATC

fluconazole; systemic

2.0

307.7

10123

44629

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

210.3

307.7

1856

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

5782

19542

L17

ICPC

Foot/toe symptom/complaint

2.1

307.7

6436

25219

N06AB05

ATC

paroxetine; oral

56.9

307.7

3149

444

N05AF03

ATC

chlorprothixene; systemic

268.5

307.7

669

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

28.5

307.7

485

122

A02BC03

ATC

lansoprazole; oral

2.1

307.7

6142

23393

F60.8

ICD-10 Finland

Other specific personality disorders

+∞

307.7

399

R06AE07

ATC

cetirizine; oral

1.8

307.7

11038

53298

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

+∞

307.7

10041

KMAK, ,

NOMESCO Finland

1.7

307.7

12796

66289

N05AN01

ATC

lithium; oral

138.1

307.7

406

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

+∞

307.7

945

T82

ICPC

Obesity

4.3

307.7

1255

2157

D11

ICPC

Diarrhoea

3.0

307.7

3363

8599

P27

ICPC

Fear of mental disorder

28.8

307.7

388

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

307.7

2347

4921

N05BE01

ATC

buspirone; oral

108.2

307.7

1437

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.9

307.7

1528

2887

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

307.7

2068

4460

G47.3

ICD-10 Finland

Sleep apnoea

3.0

307.7

6489

18242

R5140

NOMESCO Finland

Monitoring the use of the aid

2.8

307.7

2642

7167

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.7

307.7

2977

8268

P06

ICPC

Sleep disturbance

7.1

307.7

4358

5046

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.7

307.7

1544

3046

N05BA01

ATC

diazepam; systemic, rectal

8.4

307.7

4301

4253

N05AA02

ATC

levomepromazine; systemic

84.0

307.7

1130

D10

ICPC

Vomiting

3.1

307.7

1666

3986

IGY02, ,

SPAT

107.7

307.7

407

N03AX09

ATC

lamotrigine; oral

30.8

307.7

1890

465

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

3.7

307.7

2013

4031

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

8.7

307.7

2451

2165

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

24.5

307.7

5604

2050

N06AA06

ATC

trimipramine; systemic

50.0

307.7

972

142

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

7.2

307.7

1832

1920

SPAT1307

SPAT

Psychosocial counselling and guidance

11.4

307.7

2987

2061

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

306.1

307.7

1003

IHZ04, ,

SPAT

31.8

307.7

388

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.6

307.7

1554

2501

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.0

307.7

2874

4409

N05CF01

ATC

zopiclone; oral

7.4

307.7

10003

14615

SFA10

NOMESCO Finland

One-surface restoration

1.9

307.7

13984

71390

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.1

307.7

1748

4101

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

69.4

307.7

1363

146

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.3

307.7

1415

2440

SPAT1284

SPAT

Extensive health certificate

8.1

307.7

978

877

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

12.5

307.7

772

448

SPAT1234

SPAT

Support of social functional capacity

7.7

307.7

958

900

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.8

307.7

781

835

R42

ICD-10 Finland

Dizziness and giddiness

2.4

307.7

4791

15681

N03AX12

ATC

[U] gabapentin; oral

4.0

307.7

4528

9302

N05BA02

ATC

chlordiazepoxide; systemic

32.8

307.7

629

138

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

307.7

1931

5091

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

307.7

6747

26605

IGY99

NOMESCO Finland

Other psychiatric treatment contact

279.3

307.7

1065

R74

ICPC

Upper respiratory infection acute

2.2

307.7

9313

36738

SPAT1237

SPAT

Psychotherapy

45.3

307.7

318

N05AH03

ATC

olanzapine; systemic

59.5

307.7

1903

243

P16

ICPC

Acute alcohol abuse

25.2

307.7

503

143

N05AX12

ATC

aripiprazole; systemic

1487.4

307.7

1251

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.7

307.7

6452

20145

SPAT1241

SPAT

Extensive assessment of psychosocial situation

34.9

307.7

511

105

R4140

NOMESCO Finland

Psychotherapy

85.6

307.7

289

F10.20

ICD-10 Finland

Alcohol dependence currently independent

+∞

307.7

829

N06AX17

ATC

milnacipran; oral

187.1

307.7

572

F60.9

ICD-10 Finland

Personality disorder, unspecified

+∞

307.7

664

Z01.2

ICD-10 Finland

Dental examination

1.7

307.7

11457

57625

Z73.0

ICD-10 Finland

Burn-out

23.1

307.7

1543

500

AA1AD

NOMESCO Finland

CT of head and brain

2.4

307.7

5114

16794

P74

ICPC

Anxiety disorder/anxiety state

72.1

307.7

2486

269

F43.0

ICD-10 Finland

Acute stress reaction

+∞

307.7

1700

M01AG02

ATC

tolfenamic acid; oral, rectal

2.1

307.7

3654

13045

E66.8

ICD-10 Finland

Other obesity

4.3

307.7

1859

3197

N06AA09

ATC

amitriptyline; systemic

10.7

307.7

3012

2226

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.0

307.7

2836

7218

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

195.5

307.7

275

F40.1

ICD-10 Finland

Social phobias

+∞

307.7

1638

F33

ICD-10 Finland

Recurrent depressive disorder

+∞

307.7

3527

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

+∞

307.7

2420

M03BC01

ATC

orphenadrine (citrate); systemic

2.3

307.7

6074

21241

A02BC05

ATC

esomeprazole; systemic

2.1

307.7

9482

40143

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1659.5

307.7

1601

L03

ICPC

Low back symptom/complaint

2.6

307.7

7388

24699

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

307.7

8501

38951

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

307.7

440

R11

ICD-10 Finland

Nausea and vomiting

3.4

307.7

2067

4565

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.6

307.7

2983

8791

F41.3

ICD-10 Finland

Other mixed anxiety disorders

+∞

307.7

863

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

307.7

2915

8450

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.1

307.7

1476

2640

N05BA12

ATC

alprazolam; oral

15.1

307.7

4004

2190

J01CA08

ATC

pivmecillinam; oral

1.7

307.7

9250

44587

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

4.0

307.7

3275

6409

N02AX02

ATC

tramadol; systemic, rectal

2.3

307.7

10058

40219

R52.9

ICD-10 Finland

Pain, unspecified

2.7

307.7

2271

6377

F99

ICD-10 Finland

Mental disorder, not otherwise specified

+∞

307.7

831

K07.60

ICD-10 Finland

Snapping jaw

3.6

307.7

1475

2977

A06AD11

ATC

lactulose; oral

3.2

307.7

2504

5924

OAA65, ,

SPAT

3.3

307.7

5703

14355

F41.09

ICD-10 Finland

UNS Panic Syndrome

+∞

307.7

1411

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

307.7

5300

19361

N03AG01

ATC

valproic acid; systemic, rectal

9.8

307.7

1346

1013

P25

ICPC

Phase of life problem adult

10.2

307.7

1768

1305

IHZ02, ,

SPAT

77.0

307.7

557

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

456.7

307.7

1117

SPAT1254

SPAT

Administration of medicine

2.5

307.7

2859

8745

IBA03

NOMESCO Finland

Psychotherapy evaluation

881.6

307.7

612

F51

ICD-10 Finland

Nonorganic sleep disorders

+∞

307.7

1336

N76.0

ICD-10 Finland

Acute vaginitis

3.1

307.7

1837

4323

N05BA06

ATC

lorazepam; systemic, sublingual

11.0

307.7

1185

789

M79.7

ICD-10 Finland

Fibromyalgia

13.5

307.7

1474

814

N06AB04

ATC

citalopram; systemic

53.7

307.7

10689

2417

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

4.0

307.7

1919

3569

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

307.7

1092

D09

ICPC

Nausea

3.9

307.7

1301

2420

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

+∞

307.7

3377

Z2221

NOMESCO Finland

Medical doctor

2.1

307.7

6439

25399

F32

ICD-10 Finland

Depressive episode

+∞

307.7

4164

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

307.7

10067

35873

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

130.6

307.7

348

Z29

ICPC

Social problem NOS

8.3

307.7

563

487

M54.5

ICD-10 Finland

Low back pain

2.5

307.7

9658

34987

N05BA04

ATC

oxazepam; oral

19.5

307.7

11623

7507

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

+∞

307.7

1018

F60.5

ICD-10 Finland

Anankastic personality disorder

+∞

307.7

856

N06AB10

ATC

escitalopram; oral

99.9

307.7

13333

1994

L01

ICPC

Neck symptom/complaint

2.8

307.7

4169

11918

ZYC02, ,

SPAT

6.5

307.7

1008

1127

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

+∞

307.7

2664

M03BX02

ATC

tizanidine; oral

2.2

307.7

16065

79990

N05AL01

ATC

sulpiride; systemic

60.2

307.7

446

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

+∞

307.7

6398

A05

ICPC

Feeling ill

3.0

307.7

1665

4053

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

+∞

307.7

6439

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

307.7

4892

15111

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

307.7

10740

48044

N05CD07

ATC

temazepam; oral

11.1

307.7

2996

2126

ZY000

NOMESCO Finland

Hospital inpatient

50.7

307.7

453

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

307.7

6878

29506

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

307.7

4828

18814

M79.1

ICD-10 Finland

Myalgia

2.6

307.7

3640

10785

N06AX05

ATC

trazodone; oral

160.8

307.7

1525

N04BC05

ATC

pramipexole; oral

3.7

307.7

1580

3152

R51.80

ICD-10 Finland

Headache

3.4

307.7

4703

11185

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.7

307.7

811

1027

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

9044

41807

ZY010

NOMESCO Finland

Hospital outpatient

16.6

307.7

2715

1280

Z2445

NOMESCO Finland

Psychologist

17.7

307.7

1902

816

N06AX18

ATC

reboxetine; oral

147.5

307.7

594

WX290

NOMESCO Finland

Other blockage of nerve

2.0

307.7

12958

60762

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

+∞

307.7

554

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

635

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.8

307.7

1619

3119

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

307.7

10427

46790

N06AA04

ATC

clomipramine; systemic

61.9

307.7

627

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

307.7

5948

19252

R05

ICPC

Cough

2.1

307.7

5640

21810

K02.1

ICD-10 Finland

Caries of dentine

2.0

307.7

15519

79408

R21

ICPC

Throat symptom/complaint

2.2

307.7

6131

22572

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

+∞

307.7

941

F61.0

ICD-10 Finland

Mixed personality disorders

+∞

307.7

1143

SPAT1216

SPAT

Assessment of functional ability

2.6

307.7

2631

7546

F45.8

ICD-10 Finland

Other somatoform disorders

+∞

307.7

2057

F32.0

ICD-10 Finland

Mild depressive episode

+∞

307.7

1194

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

307.7

4475

14340

C07AB07

ATC

bisoprolol; oral

1.8

307.7

8625

39917

A02BC01

ATC

omeprazole; systemic

2.2

307.7

5869

21846

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

20.2

307.7

468

166

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

6693

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

2.0

307.7

14102

69382

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

107.7

307.7

642

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

307.7

3372

11313

N06AX16

ATC

venlafaxine; oral

131.4

307.7

11303

1099

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

+∞

307.7

743

SPAT1263

SPAT

Sampling

1.8

307.7

9541

45029

R01AD09

ATC

mometasone; nasal

1.8

307.7

11376

56173

N05AX08

ATC

risperidone; systemic

77.7

307.7

1806

176

N06AA12

ATC

doxepin; systemic

32.7

307.7

1885

437

N06AB08

ATC

fluvoxamine; oral

71.6

307.7

1157

119

SPAT1389

SPAT

Visit based on need for special support

8.0

307.7

844

762

F43.00

ICD-10 Finland

Acute stress reaction mild

+∞

307.7

839

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.1

307.7

6434

25386

N17

ICPC

Vertigo/dizziness

2.5

307.7

2431

7149

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

307.7

6519

22223

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.9

307.7

4345

11869

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

+∞

307.7

3397

P03

ICPC

Feeling depressed

49.8

307.7

7528

1510

N07BB01

ATC

disulfiram; oral

29.8

307.7

1648

415

Z3226

NOMESCO Finland

Physiotherapist

2.4

307.7

4050

13332

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.0

307.7

2038

5031

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

307.7

5740

21907

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

+∞

307.7

413

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

+∞

307.7

6851

F43.01

ICD-10 Finland

Acute stress reaction moderate

+∞

307.7

577

R02

ICPC

Shortness of breath/dyspnoea

2.9

307.7

2904

7715

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

307.7

4709

14309

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

8.4

307.7

514

437

N06AX26

ATC

vortioxetine; oral

603.4

307.7

6340

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

307.7

6238

23002

N06AX03

ATC

mianserin; oral

71.6

307.7

2365

256

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

+∞

307.7

379

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

+∞

307.7

398

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

+∞

307.7

535

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

10.5

307.7

510

347

SPAT1240

SPAT

Therapeutic discussion

17.3

307.7

5801

3024

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

307.2

5857

25085

N30.0

ICD-10 Finland

Acute cystitis

2.1

306.8

3448

12273

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.5

306.5

1231

2578

IAA01, ,

SPAT

35.5

300.9

250

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.8

300.9

1046

1978

Z72.1

ICD-10 Finland

Alcohol use

16.4

300.6

319

138

SPAT1235

SPAT

Mental health, emotional support

38.6

300.3

245

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

4.5

299.8

853

1378

A28

ICPC

Limited function/disability NOS

2.5

299.6

2209

6541

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

298.2

5010

20579

R06AX27

ATC

desloratadine; oral

1.7

296.4

7272

33515

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

296.0

1926

5358

R96

ICPC

Asthma

2.5

295.5

2126

6220

M54

ICD-10 Finland

Dorsalgia

2.2

295.3

2957

10036

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

7.7

291.2

486

453

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.8

290.9

1711

4511

N05AD03

ATC

melperone; systemic

58.0

290.8

221

A03

ICPC

Fever

2.0

290.3

4285

16833

J45

ICD-10 Finland

Asthma

2.4

288.8

2443

7707

OAB91, ,

SPAT

2.8

287.3

1729

4614

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.7

287.0

9879

49775

SFA30

NOMESCO Finland

Three-surface restoration

1.7

286.6

9758

49023

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

26.1

285.7

257

X23

ICPC

Fear sexually transm dis female

3.1

284.8

1410

3369

-1, ,

NOMESCO Finland

1.7

284.7

8110

38859

F84.5

ICD-10 Finland

Asperger syndrome

+∞

283.0

312

L08

ICPC

Shoulder symptom/complaint

1.9

282.8

4645

18899

S18

ICPC

Laceration/cut

1.7

282.6

9357

46625

J01DA01

ATC

[U] cefalexin

1.6

281.0

14171

78402

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

280.5

7293

34056

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

280.0

2155

6505

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2163.9

279.7

311

E66

ICD-10 Finland

Obesity

3.0

279.7

1392

3336

H01

ICPC

Ear pain/earache

2.2

279.2

2862

9794

UJF32

NOMESCO Finland

Coloscopy

1.8

279.1

5058

21231

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

279.0

12477

66966

R03DC03

ATC

montelukast; oral

2.0

277.5

3876

14914

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

276.8

5454

23487

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

15.1

276.4

305

144

N06DA02

ATC

donepezil; oral

25.0

274.5

250

Z12

ICPC

Relationship problem with partner

6.6

274.1

518

561

R03BA02

ATC

budesonide; inhalant

1.9

273.2

4030

15796

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

+∞

272.1

300

E0000UV, ,

ATC

1.6

271.7

9410

47298

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.8

271.6

1604

4234

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.2

271.2

1249

2854

K59.09

ICD-10 Finland

Constipation, unspecified

3.3

271.1

1152

2501

J01AA02

ATC

doxycycline; systemic

1.7

269.1

17596

103335

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

5.2

268.4

636

872

M01AH05

ATC

etoricoxib; oral

1.6

268.2

14557

81566

OAA81, ,

SPAT

3.9

267.6

904

1672

SPAT1265

SPAT

Breathalyser

24.2

267.6

246

F50.2

ICD-10 Finland

Bulimia nervosa

+∞

267.6

295

ZXE00

NOMESCO Finland

One hour or less

1.7

266.9

8366

40945

D06

ICPC

Abdominal pain localized other

2.5

266.8

2043

6147

J01CA04

ATC

amoxicillin; systemic

1.8

266.8

20161

123018

F41.01

ICD-10 Finland

Severe panic disorder

+∞

266.6

294

IER01

NOMESCO Finland

Psychoeducation, group

+∞

264.8

292

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

16.1

264.2

283

125

N06DA03

ATC

rivastigmine; oral, transdermal

40.8

264.0

213

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

262.4

4074

16226

A97

ICPC

No disease

1.9

262.0

3834

14966

E66.9

ICD-10 Finland

Obesity, unspecified

3.8

261.3

930

1787

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

260.2

3823

14941

M54.2

ICD-10 Finland

Cervicalgia

2.6

259.8

1792

5124

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

259.5

2582

8714

N07BA03

ATC

varenicline; oral

3.2

257.4

1162

2621

R01AD58

ATC

fluticasone, combinations; nasal

1.7

257.4

6185

28133

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

257.0

4221

17115

SGA01

NOMESCO Finland

Emergency treatment

1.9

255.9

4145

16730

K59.0

ICD-10 Finland

Constipation

3.4

254.6

1037

2188

U02

ICPC

Urinary frequency/urgency

2.1

254.5

2903

10341

R4110

NOMESCO Finland

Physiotherapy

1.8

254.3

5639

25058

L86

ICPC

Back syndrome with radiating pain

3.0

254.2

1335

3298

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

254.0

2691

9312

N05CD02

ATC

nitrazepam; oral

14.6

253.9

284

138

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

253.5

6132

27923

R01AD12

ATC

fluticasone furoate; nasal

1.7

253.1

7827

38052

IEY01

NOMESCO Finland

Psychoeducation, individual

295.6

251.6

292

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

1941.1

251.5

280

L15

ICPC

Knee symptom/complaint

1.8

251.3

5070

21904

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

+∞

251.2

277

R01AD08

ATC

fluticasone; nasal

1.7

251.1

6711

31389

SCA01

NOMESCO Finland

Preventive oral health care, short

1.7

249.3

7175

34212

R03BB04

ATC

tiotropium bromide; inhalant

2.6

249.2

1627

4522

E66.00

ICD-10 Finland

Metabolic syndrome

3.0

249.0

1300

3200

D82

ICPC

Teeth/gum disease

1.6

247.9

9086

46025

S29

ICPC

Skin symptom/complaint other

1.9

246.4

3903

15618

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

245.5

5696

25601

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

245.2

5407

23951

J01FA10

ATC

azithromycin; systemic

1.6

245.2

14285

80582

K59.1

ICD-10 Finland

Functional diarrhoea

3.2

244.7

1133

2595

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

243.3

2227

7248

P28

ICPC

Limited function/disability (P)

42.9

242.9

194

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

+∞

242.1

267

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

+∞

241.2

266

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

101.5

240.8

172

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.4

240.4

1870

5658

R00.2

ICD-10 Finland

Palpitations

2.5

240.4

1774

5236

P48

ICPC

Psychological, Clarification/discussion RFE/demand

31.6

240.1

205

SPAT1281

SPAT

Other administrative function

2.5

239.8

1702

4930

K10.3

ICD-10 Finland

Alveolitis of jaws

3.0

238.6

1230

3004

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

5.8

238.2

510

632

R06.5

ICD-10 Finland

Mouth breathing

2.3

237.9

2050

6496

ZXD05

NOMESCO Finland

Urgent procedure

1.7

237.9

6392

29861

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.7

237.8

1475

3990

IGV01

NOMESCO Finland

Psychiatric network contact

953.2

237.7

267

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

279.1

237.3

276

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

+∞

236.7

261

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.4

236.5

956

2006

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

236.2

2805

10129

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

235.9

2119

6837

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

235.8

2852

10370

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

235.7

260

F06.7

ICD-10 Finland

Mild cognitive disorder

+∞

234.8

259

K04.0

ICD-10 Finland

Pulpitis

2.2

234.1

2397

8168

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

233.8

2095

6751

J01FA06

ATC

roxithromycin; oral

1.6

233.2

8540

43084

R83

ICPC

Respiratory infection other

1.7

232.7

6798

32425

TAB00

NOMESCO Finland

Lumbar puncture

3.3

231.9

992

2160

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

6.9

231.1

422

439

P18

ICPC

Medication abuse

64.5

230.9

173

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019150) Specific gravity of Urine by Refractometry

5926

25125

1.86

323.31

3.7

3.2

1.02

kg/l

0.29

711

4085

(3021601) Nitrite [Presence] in Urine by Test strip

11821

61300

1.68

317.89

4.9

4.2

0.00

estimate

0.28

2426

11035

(3009261) Glucose [Presence] in Urine by Test strip

11902

61901

1.67

315.74

3.7

3.0

0.01

0.00

estimate

0.51

2351

10718

(3021387) Prolactin [Units/volume] in Serum or Plasma

1749

4482

2.87

313.73

1.6

291.94

282.93

mu/l

0.39

1564

4141

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2885

9477

2.29

312.34

2.8

2.4

35.08

42.65

u/l

1.89

2468

8241

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2376

7173

2.47

309.94

3.0

3.8

4.46

4.58

pmol/l

5.06

2092

6608

(3006315) Basophils [#/volume] in Blood

13091

60286

2.11

307.65

5.7

5.8

0.04

e9/l

4.58

11415

53033

(3019069) Monocytes/100 leukocytes in Blood

12151

57190

1.96

307.65

6.1

6.2

8.11

8.47

30.11

11372

54243

(3024561) Albumin [Mass/volume] in Serum or Plasma

10835

44215

2.28

307.65

4.6

5.1

36.78

36.21

g/l

22.78

10068

41512

(3037467) Urinalysis macro (dipstick) panel - Urine

16477

85412

2.05

307.65

4.5

3.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23053

118412

5.89

307.65

5.9

4.0

1.99

2.19

mu/l

0.64

21934

109807

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8563

38019

1.89

307.65

3.5

2.7

47.18

44.23

ng/l

0.09

4736

22563

(3021589) Normoblasts [#/volume] in Blood

11128

55423

1.74

307.65

9.0

8.3

0.00

e9/l

2.00

9083

46135

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6711

12652

4.73

307.65

2.0

1.3

1.48

1.23

131.18

5963

11563

(3013826) Glucose [Moles/volume] in Serum or Plasma

13737

66299

2.02

307.65

5.0

4.2

6.52

6.60

mmol/l

3.40

12810

60677

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20725

119008

2.33

307.65

5.7

4.6

38.83

38.85

mmol/mol

0.14

19523

111992

(3016879) Cocaine [Presence] in Urine

2742

4272

4.95

307.65

2.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

23340

135084

4.36

307.65

15.5

11.3

3.92

3.95

mmol/l

42.82

22851

131061

(3022948) Iron [Moles/volume] in Serum or Plasma

4272

15365

2.15

307.65

2.3

2.5

14.18

13.94

umol/l

1.11

3972

14582

(3028707) Methadone [Presence] in Urine by Screen method

1962

297

50.32

307.65

2.4

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6057

25159

1.91

307.65

1.9

1.8

0.94

1.16

mg/l

4.61

4404

19181

(3002582) Erythrocytes [#/volume] in Urine

7240

31725

1.85

307.65

3.3

2.9

45.64

73.10

e6/l

1.84

5516

23888

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5494

21189

2.06

307.65

1.3

1.2

24.22

35.16

iu/ml

5.83

1562

7291

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7698

27063

2.45

307.65

1.4

1.2

1.24

2.06

u/ml

8.07

2049

7805

(40768797) Stomach Pathology biopsy report

4056

14473

2.16

307.65

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5355

12531

3.55

307.65

1.8

1.6

1144.74

1151.92

nmol/l

0.20

4259

9616

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3920

14065

2.14

307.65

2.3

2.5

2.46

2.38

g/l

13.58

3564

13260

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

21731

127877

2.52

307.65

12.5

9.6

90.33

85.97

ml/min/173m2

164.73

18199

104116

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21312

95325

4.94

307.65

4.8

3.6

14.23

14.74

pmol/l

174.88

19915

87631

(3028300) Cannabinoids [Presence] in Urine

2854

4923

4.47

307.65

2.3

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

12397

58598

1.97

307.65

5.7

56.08

56.39

2.40

11643

55666

(3006504) Eosinophils/100 leukocytes in Blood

12097

56869

1.96

307.65

5.8

6.0

2.86

2.89

0.83

11298

53827

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11312

44308

2.45

307.65

5.6

6.0

1.22

1.21

mmol/l

1.71

10426

40850

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

691

128.08

307.65

1.7

1.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

14596

70261

2.11

307.65

7.5

8.6

4.02

3.92

e9/l

6.16

12805

61801

(3007164) IgA [Mass/volume] in Serum or Plasma

6541

23629

2.28

307.65

1.5

1.4

2.26

2.32

g/l

1.81

3897

15425

(3026008) Bacteria identified in Urine by Culture

6944

30727

1.82

307.65

3.0

2.4

—

(40761511) CBC panel - Blood by Automated count

23519

147679

3.11

307.65

13.6

9.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2807

7720

2.75

307.65

2.1

1.7

—

(3002030) Lymphocytes/100 leukocytes in Blood

12548

59494

1.97

307.65

5.9

29.51

29.06

5.03

11782

56569

(3027008) Opiates [Presence] in Urine

2843

4917

4.46

307.65

2.2

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7629

29036

2.22

307.65

2.2

1.9

213.14

188.19

u/l

0.53

7206

27345

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

22067

128211

2.83

307.65

4.6

3.6

5.85

5.77

mmol/l

14.53

20677

119370

(3027944) Amphetamines [Presence] in Urine

2743

4913

4.29

307.65

2.2

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7195

23058

2.68

307.65

2.3

2.1

2.76

2.87

mg/l

3.40

6177

20073

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13048

57243

2.26

307.65

5.7

6.3

9.69

11.19

umol/l

56.16

12230

54628

(3023323) Follitropin [Units/volume] in Serum or Plasma

2320

6406

2.70

307.65

1.4

1.3

24.50

29.64

iu/l

10.09

1979

5634

(3021960) Folate [Moles/volume] in Serum or Plasma

6721

17824

3.26

307.65

1.5

1.4

20.25

20.43

nmol/l

0.42

5933

15407

(3022096) Basophils/100 leukocytes in Blood

11643

54958

1.92

307.65

5.9

6.0

0.70

0.69

0.17

10830

51859

(3001604) Monocytes [#/volume] in Blood

13056

60178

2.10

307.65

5.7

5.8

0.55

0.56

e9/l

4.37

11407

52993

(46235355) HIV 1 and 2 tests - Meaningful Use set

6870

29803

1.86

307.65

2.1

1.8

—

(3035350) Ketones [Presence] in Urine by Test strip

11869

61016

1.70

307.65

3.7

3.0

0.00

estimate

0.71

2493

11485

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5305

16083

2.68

307.65

2.3

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4765

15967

2.36

307.65

2.4

3.3

2.42

2.45

mmol/l

34.94

4131

14138

(3015736) pH of Urine

10318

48146

1.86

307.65

3.3

2.8

5.93

5.85

1.76

798

4958

(3000764) Benzodiazepines [Presence] in Urine

2842

4843

4.53

307.65

2.2

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2481

3044

6.25

307.65

2.3

1.2

—

(3018418) pH of Serum or Plasma

7523

28632

2.21

307.65

3.8

4.4

7.40

2.06

1360

5398

(3013707) Erythrocyte sedimentation rate by Westergren method

18631

90853

2.75

307.65

4.3

3.7

10.42

10.66

mm/h

1.75

17452

85048

(3044889) 12 lead EKG panel

15901

84804

1.88

307.65

3.5

3.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5190

20008

2.04

307.65

1.3

1.2

7.59

13.52

u/ml

8.84

2001

8323

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3666

8416

3.42

307.65

2.0

2.4

366.46

378.11

nmol/l

2.52

3325

7872

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

504

301

11.99

307.65

2.7

2.2

42157.58

40494.68

ug/l

0.73

504

301

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5928

18539

2.64

307.65

1.7

1.6

26127987.34

48107612.74

pmol/l

2.00

5033

15823

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12054

45834

2.64

307.65

2.5

2.2

7444.04

76.77

nmol/l

0.50

11126

42258

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23918

149485

4.06

307.65

11.5

8.5

27.93

26.94

u/l

8.93

23377

144866

(3013115) Eosinophils [#/volume] in Blood

13453

62520

2.11

307.65

5.8

5.9

0.19

e9/l

2.29

11911

55698

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10089

38676

2.40

307.65

3.5

3.1

32.30

32.99

u/l

0.16

9544

37021

(3015377) Calcium [Moles/volume] in Serum or Plasma

9232

32438

2.59

307.65

2.8

3.8

2.35

2.36

mmol/l

6.22

8263

29198

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11537

37025

3.22

307.65

2.1

1.7

98.98

97.92

pmol/l

1.37

6335

19231

(3037522) Nuclear Ab [Titer] in Serum

4410

16851

2.02

307.65

1.4

1.3

485.73

593.63

titre

2.97

838

3515

(3036180) Methadone [Presence] in Urine

384

28.85

307.65

2.2

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

18795

91134

2.83

307.65

7.6

7.2

75.37

76.31

u/l

2.39

17788

86448

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1255

1300

7.09

307.65

1.4

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

13478

62500

2.12

307.65

5.7

5.8

1.99

1.94

e9/l

2.70

12041

56203

(3018095) Leukocytes [#/volume] in Urine

8605

38815

1.85

307.65

3.8

3.2

57.65

78.71

e6/l

3.07

5974

26141

(3009508) Creatinine [Moles/volume] in Urine

7906

33716

1.95

307.65

3.2

8.13

8.01

mmol/l

1.15

6775

29300

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22948

137093

3.22

307.65

14.8

10.1

19.12

22.80

mg/l

55.27

18609

103096

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

8719

33014

2.32

307.65

2.9

2.4

55.48

64.01

u/l

3.96

8036

30870

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5786

18158

2.61

307.65

2.4

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

18614

92343

2.65

307.65

3.9

2.5

45.71

41.42

u/l

8.22

17607

87894

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4168

15626

2.05

307.65

3.5

3.8

0.82

mmol/l

1.31

3910

14889

(3011288) Drugs identified in Urine by Screen method

2482

2018

9.49

307.65

3.0

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12417

49361

2.53

307.65

6.2

6.8

1.22

mmol/l

0.06

10656

42334

(3031040) Bacteria [#/volume] in Urine by Automated count

15691

78270

2.10

307.65

4.7

3.4

977.48

1154.68

e6/l

0.18

190

967

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3410

10082

2.60

307.65

2.2

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

9810

47679

1.74

307.65

10.5

11.1

1.12

1.21

inr

10.44

3016

14014

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13908

51215

3.06

307.65

3.2

2.6

90.19

116.75

ug/l

25.65

13043

48418

(3019550) Sodium [Moles/volume] in Serum or Plasma

23316

134476

4.37

307.65

15.4

11.1

139.59

139.79

mmol/l

35.82

22867

130787

(36304419) Bacteria [Presence] in Urine

6655

28290

1.89

307.65

3.1

2.7

—

(3030467) Casts [#/volume] in Urine by Automated count

6743

28707

1.89

307.65

3.2

2.8

0.30

0.37

e6/l

2.50

5107

21301

(3048689) Calprotectin [Mass/mass] in Stool

4653

14676

2.51

307.65

2.3

2.7

106.78

140.16

ug/g

9.17

3609

11986

(40760892) CBC W Ordered Manual Differential panel - Blood

12322

56634

2.05

307.65

6.0

6.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

6602

28124

1.88

307.65

1.7

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

5147

21192

1.89

305.01

2.7

2.4

6.82

5.61

e6/l

5.98

4598

19000

(36660697) Celiac disease serology panel - Serum

2860

9456

2.27

304.55

1.2

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

6451

28789

1.78

293.30

4.3

3.6

96.40

93.20

21.15

6240

28118

(1002224) Polysomnography panel

1877

5181

2.67

292.74

1.1

1.0

—

(40758558) Short blood count panel - Blood

6543

29368

1.77

291.38

5.8

6.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3565

13138

2.06

288.34

2.4

2.6

23.04

23.70

1.87

3116

11434

(3020191) Ethanol [Moles/volume] in Serum or Plasma

440

374

8.40

282.55

1.8

1.1

1.70

0.86

promille

16.12

341

299

(3002385) Erythrocyte distribution width [Ratio]

20148

122339

1.82

281.66

16.4

12.1

15.00

14.71

0.72

19829

120084

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

17693

103662

1.69

278.99

3.9

2.9

—

(3026782) Osmolality of Urine

4805

19907

1.86

275.91

2.9

2.7

528.96

556.27

mosm/kgh2o

11.52

4124

17208

(3017143) Hepatitis C virus Ab [Presence] in Serum

4181

16624

1.92

271.61

1.7

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

309

156

14.09

271.25

2.1

1.3

173.09

79.56

umol/l

2.46

172

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3283

12200

2.03

257.38

5.6

6.9

1.04

mmol/l

0.13

3085

11561

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2484

8301

2.23

255.49

2.7

2.1

12.35

12.91

nmol/l

2.50

2217

7774

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2609

9008

2.16

247.31

1.2

122.24

165.65

iu/ml

6.20

928

3658

(3007853) Bacteria identified in Skin by Aerobe culture

3262

12418

1.97

237.71

1.8

1.6

—

(3023368) Bacteria identified in Blood by Culture

5682

25717

1.72

237.66

4.4

3.9

—

(3013512) EKG study

6462

30344

1.67

235.45

3.6

3.2

—

(3009343) pH of Capillary blood

1732

5159

2.46

229.93

3.1

3.2

7.41

7.42

0.65

201

643

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2585

9144

2.10

229.44

2.4

0.23

0.22

g/l

4.24

2359

8699

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1747

5236

2.45

228.86

3.1

3.2

5.19

5.09

kpa

5.53

1665

4979

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3217

12339

1.96

228.80

2.9

6.37

8.07

umol/l

6.06

2682

10955

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1053

2410

3.16

227.49

1.4

288.41

279.30

ug/g

0.41

567

1409

(3019225) pH of Specimen

2594

9221

2.09

227.20

3.7

4.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1390

3733

2.71

226.95

1.4

9.35

10.06

u/l

0.98

1105

3151

(3023511) Choriogonadotropin [Units/volume] in Urine

1049

2404

3.16

226.13

1.4

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2015

6531

2.27

221.43

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4168

17565

1.80

221.06

2.7

2.5

0.99

1.04

e6/l

0.33

2264

9839

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1316

3486

2.75

220.37

1.9

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1663

4969

2.45

219.00

3.0

3.2

1.38

1.53

mmol/l

1.02

1226

3599

(3009542) Hematocrit [Volume Fraction] of Blood

24415

162190

3.80

218.74

21.7

14.4

40.60

41.21

5.95

23450

153241

(3007461) Platelets [#/volume] in Blood

24430

162430

3.84

216.33

21.7

14.4

266.18

254.49

e9/l

150.65

24057

158123

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1823

5763

2.32

211.87

2.4

2.3

4271.64

6066.84

u/l

1.83

609

2683

(3035941) MCH [Entitic mass]

24438

162676

3.82

211.37

21.6

14.3

30.17

30.14

1.72

24237

160657

(3026361) Erythrocytes [#/volume] in Blood

24441

162726

3.83

210.83

21.7

14.3

4.54

4.58

e12/l

38.42

24020

158043

(3024731) MCV [Entitic volume]

24438

162700

3.81

210.62

21.6

14.3

90.40

90.25

5.67

24237

160675

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3555

14470

1.85

209.92

1.9

1.7

—

(3010813) Leukocytes [#/volume] in Blood

24439

162759

3.80

209.12

21.7

14.3

6.74

6.54

e9/l

41.34

24016

158023

(3000963) Hemoglobin [Mass/volume] in Blood

24444

162842

3.81

208.23

21.8

14.4

136.17

137.45

g/l

41.79

24242

160824

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3892

16447

1.79

202.79

2.8

2.6

3.96

2.94

e6/l

3.94

1992

8792

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1941

6435

2.22

201.45

1.1

1.0

—

(3025941) Bacteria identified in Stool by Culture

1999

6755

2.17

197.89

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

967

2300

3.03

195.69

2.1

1.8

195.12

198.50

pmol/l

0.38

901

2229

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

922

2162

3.07

191.03

1.3

464.43

549.63

mg/l

2.77

878

2076

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21993

140978

1.82

190.84

4.8

4.1

2.88

2.90

mmol/l

1.75

20633

133004

(3029937) Albumin [Presence] in Urine by Test strip

6444

31641

1.58

188.36

4.1

3.3

0.00

estimate

0.30

2363

10676

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3101

12550

1.84

184.60

6.6

5.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

5664

27165

1.60

181.63

3.7

3.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9044

48176

1.50

180.81

3.8

3.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1260

3619

2.52

179.38

2.0

1.6

37.01

40.64

nmol/l

5.93

1229

3556

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

828

1893

3.15

178.75

1.4

1.5

1058.75

1389.88

e6/l

0.42

665

1527

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1167

3237

2.61

178.20

3.2

3.4

24.78

24.71

mmol/l

0.44

1102

3014

(3022313) Gas panel - Capillary blood

1281

3724

2.50

177.85

3.2

3.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

826

1892

3.14

177.76

1.4

29.38

38.83

e6/l

0.36

636

1463

(3022145) Colonoscopy Study observation

3190

13182

1.80

176.97

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4242

19045

1.68

175.74

3.6

3.1

307.73

695.13

ng/l

5.24

2620

13531

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

21730

139510

1.74

174.28

4.4

3.8

4.77

4.82

mmol/l

11.57

20485

132390

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

810

1859

3.13

173.73

1.4

1.3

24.72

28.68

u/l

2.27

637

1593

(3023183) Ammonium ion [Moles/volume] in Plasma

650

1295

3.60

173.08

3.1

2.9

35.22

34.43

umol/l

0.20

600

1203

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1454

4542

2.33

172.62

1.3

1.2

0.39

0.96

u/ml

2.28

119

371

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

659

1330

3.55

172.24

1.5

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1330

4008

2.41

170.94

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

816

1904

3.08

170.29

1.2

1.3

3.76

3.65

mmol/l

1.96

764

1794

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

742

1637

3.25

169.51

1.6

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2101

7691

2.01

167.57

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

21581

138662

1.70

165.95

4.4

3.7

1.42

1.49

mmol/l

104.80

20273

131249

(4200892) Spirometry reversibility

2084

7680

1.99

162.94

1.5

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

2178

8154

1.96

162.84

1.3

201.20

240.98

u/ml

1.06

2013

7606

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

20941

133652

1.63

162.77

4.0

3.4

1.41

1.26

mmol/l

113.10

19527

125941

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5229

25231

1.58

160.40

2.8

835.23

1041.50

ng/l

2.60

4184

21511

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1458

4704

2.25

160.37

1.1

12.30

6.73

u/ml

0.20

(3014111) Lactate [Moles/volume] in Serum or Plasma

2099

7844

1.96

157.52

6.8

7.9

1.33

1.27

mmol/l

1.34

2039

7680

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2202

8371

1.93

157.23

2.4

2.3

21.17

22.28

au/ml

0.19

147

810

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2044

7631

1.96

153.67

1.3

53.50

52.79

au/ml

0.04

440

(3044640) Blood type and Crossmatch panel - Blood

7320

38461

1.48

149.23

2.4

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2403

9563

1.85

148.87

1.8

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1702

6018

2.06

148.51

1.1

165.70

219.85

titre

0.36

204

(3042936) Bacteria identified in Isolate by Culture

3416

15089

1.69

147.91

2.2

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2094

8020

1.91

145.77

4.2

4.0

5.91

5.81

kpa

4.97

2028

7828

(3009466) Valproate [Moles/volume] in Serum or Plasma

293

344

6.05

144.05

2.9

326.24

380.39

umol/l

5.01

236

282

(3005719) IgG [Mass/volume] in Serum or Plasma

2229

8780

1.86

142.29

2.3

2.8

10.39

10.67

g/l

2.64

2000

8118

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2398

9670

1.82

142.08

1.8

1.6

—

(3002032) Base excess in Venous blood by calculation

2076

8013

1.90

140.98

4.3

4.0

1.78

1.80

mmol/l

0.11

1793

6917

(3000494) Fungus identified in Specimen by Culture

3098

13495

1.70

140.66

1.5

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

202

153

9.35

140.56

1.0

858.63

857.26

ng/l

0.01

128

105

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

202

153

9.35

140.56

1.0

33.57

29.76

ng/l

0.64

132

102

(3012544) pH of Venous blood

2143

8374

1.87

140.13

4.2

4.0

7.36

7.38

0.92

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

200

153

9.26

138.24

1.0

246.78

480.14

ng/l

0.46

132

106

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6280

32397

1.48

138.11

1.7

1.6

1.55

1.33

mmol/l

41.40

5367

27764

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3448

15533

1.65

137.65

2.1

2.3

29.42

29.68

1.94

3341

15106

(42529406) Shigella sp [Presence] in Stool by Culture

1028

3086

2.40

132.68

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1993

7741

1.88

132.44

3.6

3.8

1.23

mmol/l

1.98

1688

6906

(3026493) Urate [Moles/volume] in Serum or Plasma

6067

31318

1.48

131.89

2.4

2.5

2595.95

4054.94

umol/l

2.92

5315

28415

(3014765) Yersinia sp identified in Stool by Organism specific culture

1024

3077

2.40

131.87

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

730

1852

2.82

131.55

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1015

3053

2.39

130.41

1.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1723

6406

1.96

130.29

3.6

3.2

4.79

4.71

kpa

0.68

1659

6234

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10635

61028

1.39

128.08

2.6

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5128

25723

1.51

127.61

1.7

—

(3000991) Gas panel - Venous blood

1942

7671

1.85

122.07

8.3

9.4

—

(40768804) Tissue Pathology biopsy report

9449

53483

1.39

121.33

2.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1255

4287

2.11

119.19

1.6

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1341

4708

2.06

118.54

1.7

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5581

28918

1.46

116.51

2.4

2.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

6541

34920

1.43

116.38

3.2

2.7

—

(3012516) Albumin [Mass/volume] in Urine

5993

31601

1.44

113.54

3.3

361.25

393.35

mg/l

0.21

3854

19856

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1200

4105

2.11

113.44

4.5

4.6

24.13

24.10

mmol/l

0.11

1163

4048

(3020682) Albumin/Creatinine [Ratio] in Urine

6254

33258

1.43

113.05

3.9

8.52

8.57

mg/mmol

0.03

3936

21057

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1512

5688

1.92

109.93

1.6

1.7

3.42

3.92

mg/l

1.41

1244

3782

(3027945) Reticulocytes/100 erythrocytes in Blood

2298

9861

1.70

108.45

2.3

2.8

1.78

1.74

1.04

2001

8978

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

892

2774

2.31

106.15

2.3

2.5

349.93

601.81

ug/l

1.25

818

2594

(3001019) Free T4 and TSH panel - Serum or Plasma

1959

8087

1.76

105.91

1.8

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1712

6810

1.82

104.65

1.8

1.29

1.30

g/l

0.10

1550

6305

(3019832) Treponema pallidum Ab [Presence] in Serum

3707

18036

1.52

103.95

1.8

1.7

—

(40761535) Cells panel - Urine sediment

1945

8083

1.75

102.63

3.5

3.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

719

2092

2.46

98.98

1.5

1.4

0.39

0.46

nmol/l

0.82

545

1663

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

376

762

3.51

97.63

1.6

2.1

19.67

18.87

nmol/l

0.82

346

736

(3027801) Oxygen [Partial pressure] in Arterial blood

2330

10309

1.65

97.44

7.6

7.9

12.22

13.49

kpa

24.48

2242

9871

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2330

10310

1.65

97.40

7.6

7.9

5.11

5.08

kpa

1.11

2243

9878

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4953

25895

1.43

95.62

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1395

5350

1.88

95.39

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2957

13939

1.56

94.96

4.2

3.9

30.12

32.28

22.78

2265

10010

(3003396) Base excess in Arterial blood by calculation

2317

10332

1.64

93.78

7.7

7.9

0.93

0.89

mmol/l

0.21

1863

8227

(3008898) HLA-B27 [Presence]

1276

4790

1.92

93.00

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2453

11148

1.61

91.86

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1719

7118

1.75

91.47

3.6

4.3

81.14

90.56

ng/l

3.61

1488

6324

(3006653) Thiamine [Moles/volume] in Blood

233

344

4.80

90.75

1.4

1.3

138.73

135.08

nmol/l

0.45

233

344

(3023410) Appearance of Cerebral spinal fluid

402

904

3.16

88.99

1.5

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3300

16150

1.50

88.71

1.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

603

1726

2.49

85.87

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1748

7401

1.71

85.77

2.4

2.0

6.97

8.70

ug/l

1.51

1483

6698

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

603

1728

2.49

85.67

1.3

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

445

1090

2.90

85.32

1.3

1.2

27.43

28.82

nmol/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1030

3711

1.99

84.35

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1706

7243

1.70

82.78

1.3

1.5

—

(1616796) Gas panel - Central venous blood

629

1874

2.39

82.26

3.0

3.4

—

(40761536) Microorganisms panel - Urine sediment

2179

9876

1.60

82.03

4.0

3.3

—

(3016502) Oxygen saturation in Arterial blood

2053

9188

1.62

81.34

8.2

8.4

95.54

96.29

5.63

2000

8830

(3017732) Neutrophils [#/volume] in Blood

1929

8507

1.64

81.01

2.3

2.4

4.67

4.64

e9/l

0.03

1547

7207

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1420

5761

1.78

80.74

6.5

7.9

24.83

24.70

mmol/l

0.66

1405

5723

(3007566) Smooth muscle Ab [Titer] in Serum

929

3329

2.00

77.17

1.3

61.71

137.70

titre

3.63

335

(3010421) pH of Blood

704

2274

2.21

76.49

3.5

3.4

7.41

7.42

3.10

642

2098

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

705

2285

2.20

75.97

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1884

8392

1.63

75.86

8.0

9.0

7.94

9.11

mmol/l

12.08

1796

8073

(3035637) Corticotropin [Mass/volume] in Plasma

457

1213

2.68

75.65

1.5

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

918

3302

1.99

75.44

1.2

1.3

600.50

1174.44

titre

1.32

108

(3016018) Differential panel - Cerebral spinal fluid

400

990

2.87

75.33

1.4

1.5

—

(3000492) Spirometry study

2826

13825

1.49

75.13

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1191

4725

1.81

72.79

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

549

1633

2.39

72.05

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

934

3446

1.94

71.36

1.3

32.07

43.61

u/ml

0.74

238

(3016244) Insulin [Units/volume] in Serum or Plasma

317

709

3.17

70.85

3.6

3.2

34.52

24.96

mu/l

3.32

294

668

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

968

3635

1.91

70.20

1.1

2.96

5.56

u/ml

2.84

142

555

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

963

3625

1.90

69.32

1.8

0.23

g/l

0.12

921

3449

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

984

3737

1.89

68.96

1.8

1.21

1.17

g/l

4.03

943

3574

(3012501) Base excess in Blood by calculation

616

1966

2.23

68.87

3.5

3.4

2.44

2.38

mmol/l

0.17

412

1298

(3013290) Carbon dioxide [Partial pressure] in Blood

616

1967

2.23

68.79

3.5

3.4

5.04

4.95

kpa

2.48

601

1927

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1232

5023

1.76

68.66

2.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1280

5282

1.74

68.42

1.4

1.5

—

(3020891) Body temperature

898

3317

1.94

68.36

5.3

4.5

—

(3027315) Oxygen [Partial pressure] in Blood

620

1991

2.22

68.31

3.5

3.4

8.98

8.87

kpa

0.85

605

1951

(3023520) Reticulocytes [#/volume] in Blood

1621

7153

1.63

67.49

2.4

2.9

74.51

70.31

e9/l

3.86

1182

5384

(3052851) Hemolysis interference index of Serum or Plasma

828

2989

1.98

67.31

2.8

2.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

260

530

3.47

67.05

1.5

1.4

—

(3003181) Sodium [Moles/volume] in Urine

416

1134

2.61

65.43

1.5

1.3

59.25

65.85

mmol/l

2.14

308

922

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

362

923

2.78

64.66

1.2

1.1

38.39

46.13

mg/l

2.05

303

792

(3026389) Candida sp identified in Specimen by Organism specific culture

494

1479

2.38

63.93

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1900

8819

1.56

63.92

3.5

4.1

0.52

0.70

2.41

538

2695

(3004119) Hemoglobin [Mass/volume] in Venous blood

1296

5476

1.70

63.57

3.7

3.3

132.61

130.28

g/l

3.09

1266

5365

(3019060) Gas panel - Arterial blood

1304

5520

1.70

63.53

5.5

5.0

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

18.04

62.84

1.2

1.1

—

mmol/l

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

352

899

2.78

62.69

1.1

257.45

267.13

mg/l

0.22

310

802

(3015235) Bicarbonate [Moles/volume] in Capillary blood

627

2098

2.13

62.42

2.7

2.9

24.44

24.48

mmol/l

0.10

612

2058

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

669

2296

2.08

62.39

1.3

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

303

715

3.00

62.05

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

1965

9252

1.54

61.93

3.6

4.3

0.11

0.12

0.36

525

2701

(3017181) Myelocytes/100 leukocytes in Blood

2036

9662

1.52

61.89

3.6

4.3

0.76

0.97

2.75

595

3105

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1110

4536

1.75

61.27

1.3

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

720

2558

2.01

61.18

1.2

1.3

35.81

47.44

u/ml

0.95

269

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1160

4810

1.73

60.84

8.9

10.7

24.12

24.25

mmol/l

0.64

1122

4715

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

60.65

1.4

0.0

543.78

—

nmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2145

10362

1.50

59.84

3.5

2.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1859

8717

1.54

59.60

8.8

123.97

122.16

g/l

3.16

1823

8472

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

269

607

3.14

59.34

1.4

1.2

5.21

5.66

umol/l

0.86

237

566

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

334

857

2.76

59.00

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

560

1842

2.16

58.21

2.9

2.8

8.57

8.48

kpa

0.58

544

1804

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1322

5747

1.65

58.16

9.3

10.0

1.47

1.27

9.12

1317

5717

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1221

5202

1.68

57.99

2.0

2.2

40.06

39.88

u/l

0.11

1103

4727

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

885

3445

1.84

57.36

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1617

7419

1.57

57.01

2.2

2.7

67.06

67.01

g/l

0.10

1463

6939

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

838

3219

1.86

56.63

1.3

5.69

9.78

u/ml

1.09

119

528

(3025159) Blasts/100 leukocytes in Blood

1865

8848

1.52

56.56

3.7

4.3

0.06

0.48

3.70

426

2333

(3008295) Osmolality of Serum or Plasma

290

713

2.88

55.37

1.5

279.65

281.59

mosm/kgh2o

0.70

210

598

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

232

501

3.28

54.92

1.1

1.59

8.03

nmol/l

1.27

108

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

470

1476

2.26

54.63

1.9

3152.00

2237.87

titre

0.31

(3005988) Vibrio sp identified in Specimen by Organism specific culture

424

1273

2.36

54.58

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

424

1273

2.36

54.58

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

424

1273

2.36

54.58

1.3

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

822

3176

1.85

54.53

1.3

4.70

7.58

u/ml

0.53

353

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

428

1291

2.35

54.53

1.3

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

359

997

2.55

54.48

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

433

1322

2.33

53.70

1.3

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

758

2876

1.88

53.20

4.6

4.0

1.32

1.30

mmol/l

0.32

753

2827

(3004588) Protein electrophoresis panel - Serum or Plasma

1327

5904

1.61

53.15

1.9

2.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

234

519

3.19

53.13

1.6

1.4

22.27

29.15

umol/l

2.48

221

493

(3024522) Salmonella sp identified in Specimen by Organism specific culture

426

1301

2.32

52.80

1.3

1.5

—

(44813793) Dust mix specific IgE antibody measurement

325

876

2.63

52.34

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

942

3846

1.75

52.08

1.4

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1960

9590

1.47

50.98

2.4

74.34

68.63

ml/min/173m2

7.05

758

3493

(3024891) Influenza virus A+B Ag [Presence] in Specimen

806

3175

1.81

50.25

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

11.00

49.53

1.1

1.2

47.13

39.78

mg/l

0.96

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

292

769

2.69

49.21

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

290

767

2.68

48.48

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

234

552

3.00

48.06

1.5

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

452

1478

2.17

47.73

1.2

1.3

0.13

0.25

nmol/l

2.31

(3003338) MCHC [Mass/volume]

19267

127804

1.26

47.45

18.2

12.2

332.99

333.11

g/l

1.01

19145

126841

(40767503) Oxygen content in Capillary blood by calculation

529

1847

2.04

47.17

2.4

2.3

17.19

16.75

1.31

270

925

(3027273) Bicarbonate [Moles/volume] in Venous blood

982

4212

1.67

45.35

3.7

3.3

25.32

25.36

mmol/l

0.14

958

4091

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

912

3836

1.70

45.31

4.1

3.6

50.54

48.10

2.04

905

3800

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

294

814

2.56

44.97

1.6

1.5

—

(3021901) Oxygen saturation in Capillary blood

447

1501

2.11

44.18

2.5

2.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

762

3069

1.77

44.13

1.2

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

444

1489

2.12

44.03

1.2

1.3

0.59

2.20

nmol/l

0.92

423

1439

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

360

1113

2.29

43.47

2.1

1.9

23.32

26.54

mg/l

0.47

102

281

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

743

2987

1.77

43.29

1.1

2.04

2.50

u/ml

0.51

379

1495

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1144

5161

1.59

43.12

1.4

1.3

239.56

226.37

miu/ml

0.52

506

2604

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2251

11645

1.39

42.89

3.5

5.0

227.62

245.53

u/l

7.02

2113

11185

(3024980) IgG subclass 4 [Mass/volume] in Serum

547

2001

1.94

42.83

1.5

1.6

0.71

0.79

g/l

0.92

417

1531

(3028271) Lactate [Moles/volume] in Capillary blood

406

1331

2.16

42.64

1.8

1.6

1.82

1.69

mmol/l

1.33

394

1298

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

956

4142

1.65

42.46

2.0

1.9

—

(3037121) Protein [Mass/volume] in Urine

849

3566

1.70

42.40

3.0

3.4

0.32

0.34

g/l

0.15

331

1654

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

653

2549

1.82

41.94

1.2

0.78

16.73

u/ml

—

(3006270) Folate [Moles/volume] in Blood

263

714

2.61

41.87

1.2

1.1

392.30

376.31

nmol/l

0.58

240

636

(3036489) Thrombin time

1042

4636

1.61

41.61

2.1

2.3

21.00

21.32

1.03

899

3985

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

403

1333

2.14

41.41

1.2

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

188

429

3.10

40.89

1.8

1.7

1.97

1.95

umol/l

0.16

171

402

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3207

17656

1.32

40.68

1.5

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

903

3898

1.65

40.67

1.6

400.15

364.46

titre

0.10

148

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

535

1980

1.92

40.51

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

659

2614

1.79

40.17

1.2

1.3

1.62

6.33

u/ml

2.00

214

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

935

4089

1.63

40.02

1.7

1.9

1.47

1.48

g/l

0.12

807

3509

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1081

4897

1.58

40.01

1.3

1.6

5.04

14.25

u/ml

4.27

187

(3024928) Oxygen saturation in Venous blood

514

1889

1.93

39.73

3.8

3.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

866

3721

1.66

39.71

1.9

1.7

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

187

438

3.02

38.97

1.3

1.5

73.36

71.70

0.74

178

424

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

139

270

3.63

38.64

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1188

5544

1.53

38.54

8.5

6.9

24.59

24.52

mmol/l

0.26

1148

5246

(3022806) Fractional oxyhemoglobin in Capillary blood

343

1097

2.21

38.31

1.8

1.6

90.53

90.73

0.28

335

1080

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

183

428

3.02

38.24

1.3

1.5

424.88

545.89

mu/l

0.78

174

414

(3045414) Leukocytes [Presence] in Urine

1128

5213

1.55

38.24

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

750

3142

1.70

37.82

1.9

2.0

16.10

13.01

iu/l

0.09

258

1278

(3016650) Hepatitis A virus Ab [Presence] in Serum

530

2009

1.87

37.36

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

194

479

2.86

36.94

1.5

1.6

1.91

8.21

nmol/l

0.71

142

407

(3003888) Timothy IgE Ab [Units/volume] in Serum

663

2703

1.74

36.84

1.1

5.33

5.95

u/ml

0.43

353

1421

(3025130) Human papilloma virus identified in Specimen

548

2115

1.84

36.53

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

227

614

2.61

36.47

1.4

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

154

335

3.25

36.22

1.6

2.4

0.75

1.09

ug/l

1.28

143

316

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

236

655

2.55

36.03

1.1

1.07

1.13

u/l

0.32

297

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

221

603

2.59

34.93

1.2

1.6

6.69

5.83

u/l

0.30

177

513

(3028192) IgG subclass 2 [Mass/volume] in Serum

358

1212

2.09

34.75

1.3

1.4

2.95

3.07

g/l

0.68

252

847

(3024139) IgG subclass 3 [Mass/volume] in Serum

358

1212

2.09

34.75

1.3

1.4

0.33

0.42

g/l

5.42

253

846

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

164

382

3.03

34.56

1.8

1.7

29.15

29.50

umol/l

0.16

157

371

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

147

320

3.24

34.56

1.3

1.5

12.91

15.72

pmol/l

3.79

124

280

(4062490) Immunoglobulin typing, IgG

358

1216

2.09

34.45

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

357

1215

2.08

34.19

1.3

1.4

6.35

6.96

g/l

2.52

250

849

(3008401) Mugwort IgE Ab [Units/volume] in Serum

628

2578

1.73

34.08

1.1

0.81

1.25

u/ml

1.43

268

1102

(3010726) Horse dander IgE Ab [Units/volume] in Serum

624

2559

1.73

33.99

1.1

2.18

1.95

u/ml

0.26

319

1227

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

246

718

2.42

33.86

1.2

1.93

2.03

mmol/l

0.70

231

673

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

630

2595

1.73

33.79

1.9

2.2

38.53

38.31

g/l

0.36

555

2357

(3006184) Hemoglobin [Mass/volume] in Capillary blood

548

2168

1.79

33.75

2.0

2.1

133.99

132.01

g/l

0.97

388

1548

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

585

2374

1.75

33.06

1.9

2.2

0.00

g/l

0.87

532

2214

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

689

2927

1.67

33.01

1.2

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

267

824

2.29

32.51

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

266

822

2.29

32.29

1.2

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

529

2099

1.79

32.28

1.1

21.99

12.80

au/ml

0.84

159

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

302

986

2.17

32.17

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

620

2585

1.70

31.85

1.9

2.2

0.02

0.03

g/l

0.35

566

2419

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

673

2869

1.67

31.83

2.1

2.4

0.52

0.80

g/l

1.74

595

2558

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

649

2741

1.68

31.79

1.3

274.19

260.93

u/ml

0.53

432

1816

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

506

2000

1.79

31.28

2.6

3.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

732

3211

1.62

30.97

1.9

2.3

2.86

2.92

g/l

0.83

657

2978

(3011985) Renin [Units/volume] in Plasma

411

1526

1.91

30.92

1.7

1.6

80.23

60.44

mu/l

0.76

359

1380

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

204

569

2.53

30.92

1.1

10.67

10.90

u/ml

0.03

116

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

826

3733

1.57

30.87

2.5

2.7

179.30

182.79

0.55

785

3558

(3029634) Reagin Ab [Titer] in Serum by VDRL

492

1941

1.80

30.62

2.2

8.43

6.20

titre

0.29

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

7.32

30.58

1.2

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

123

260

3.34

30.32

1.2

1.3

26.53

18.28

0.39

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

270

863

2.21

30.31

1.1

292.09

290.58

mg/l

0.10

233

794

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

167

4.01

30.31

1.3

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

763

3402

1.59

30.20

1.9

2.3

7.17

7.33

g/l

1.87

688

3168

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

719

3160

1.62

30.19

1.9

2.3

9.68

10.31

g/l

4.13

640

2909

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

569

2356

1.71

29.99

2.0

2.3

0.00

g/l

-0.00

527

2213

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

761

3399

1.59

29.90

1.9

2.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

763

3412

1.59

29.83

2.1

2.3

10.60

10.69

mg/l

0.12

717

3211

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

384

1418

1.92

29.39

1.4

347.17

474.33

pmol/l

0.67

335

1249

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

757

3396

1.58

29.21

1.9

2.3

3.65

3.69

g/l

0.33

686

3163

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

495

1985

1.77

29.19

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

352

1266

1.97

29.08

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

502

2030

1.75

28.77

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

103

200

3.63

28.77

1.4

1.1

103.51

115.45

nmol/l

0.49

162

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

160

409

2.76

28.74

1.2

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

223

672

2.34

28.72

1.4

1.6

6.45

8.25

ug/l

1.39

201

614

(3004616) Nuclear Ab [Presence] in Serum

389

1457

1.89

28.55

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

187

522

2.53

28.34

1.4

1.2

335.37

385.50

u/l

0.20

176

486

(3016038) Potassium [Moles/volume] in Urine

170

453

2.65

28.24

1.4

1.2

33.38

36.42

mmol/l

0.75

136

407

(3014133) Dog dander IgE Ab [Units/volume] in Serum

536

2222

1.71

28.15

1.1

5.45

3.77

u/ml

0.95

248

1066

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

177

484

2.58

27.97

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

425

1650

1.82

27.91

1.1

1.49

1.48

g/l

0.18

381

1503

(40768443) Skin Pathology biopsy report

1061

5196

1.45

27.14

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

125

287

3.07

27.09

2.4

2.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

265

881

2.13

27.07

1.3

1.67

1.86

u/ml

0.09

142

485

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

700

3140

1.58

27.04

1.4

1.5

20.91

13.25

iu/ml

0.48

(43055514) Macroprolactin [Presence] in Serum or Plasma

135

325

2.93

27.01

1.3

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

167

453

2.60

26.83

1.1

1.3

62.27

71.12

0.43

(3028679) Herpes simplex virus Ab [Presence] in Serum

230

726

2.24

26.67

1.2

—

(3002256) Pathology report gross observation

2894

16537

1.26

26.61

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

132

319

2.92

26.25

1.3

—

(3007463) Buprenorphine [Presence] in Urine

+∞

26.24

6.0

0.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

542

2302

1.67

26.06

2.7

2.2

0.94

0.81

nmol/l

3.09

446

1973

(3017509) Phencyclidine [Presence] in Urine

106

4.59

25.98

1.4

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

430

1724

1.77

25.43

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

863

4126

1.49

24.94

2.3

2.4

94.68

93.32

0.95

827

3972

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

804

3792

1.51

24.82

2.8

2.9

3.65

3.59

g/l

0.53

763

3630

(3014271) Vancomycin [Susceptibility]

112

258

3.06

24.20

3.0

2.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

503

2140

1.67

24.07

1.2

102.50

158.93

titre

—

(3001186) Copper [Moles/volume] in Serum or Plasma

109

250

3.07

23.73

1.5

1.2

17.01

16.85

umol/l

0.12

226

(3023430) Cat dander IgE Ab [Units/volume] in Serum

489

2076

1.67

23.60

1.1

7.22

4.46

u/ml

0.79

203

869

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

490

2084

1.67

23.48

1.1

2.49

3.03

u/ml

0.69

229

1127

(3034274) Bile acid [Moles/volume] in Serum --fasting

490

2084

1.67

23.48

2.1

2.3

5.74

6.32

umol/l

0.42

368

1525

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

155

436

2.51

23.23

1.4

1.3

0.30

0.31

g/l

0.64

125

355

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

437

1808

1.71

23.20

1.7

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

173

514

2.38

23.10

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

109

255

3.01

22.98

1.6

2.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

317

1194

1.88

22.98

1.2

57.74

62.11

u/l

0.76

285

1085

(3045683) HLA typing for celiac disease panel - Blood or Tissue

247

853

2.05

22.94

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

636

2907

1.55

22.70

1.4

1.5

22.30

21.88

u/ml

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

141

3.80

22.69

1.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

642

2941

1.55

22.69

2.0

1.6

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

+∞

22.62

1.3

0.0

209.74

—

nmol/l

—

(3022621) pH of Urine by Test strip

1449

7723

1.34

22.45

2.8

2.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

137

369

2.62

22.41

2.5

2.3

55.25

48.00

umol/l

1.89

118

326

(3039162) Centromere protein B Ab [Units/volume] in Serum

394

1602

1.74

22.27

1.2

1.3

48.02

58.70

u/ml

0.31

105

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1095

5595

1.39

22.14

2.7

2.5

0.33

0.27

e6/l

0.60

1063

5423

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

728

3449

1.50

22.03

2.2

2.0

2.26

2.50

ug/l

0.17

647

3128

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

213

707

2.13

21.95

2.2

2.3

102.66

97.13

1.24

196

649

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

144

403

2.52

21.84

1.6

1.3

957382.25

2944144.00

iu/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

239

832

2.03

21.75

1.1

8.81

8.44

iu/ml

0.07

228

(3021367) Citalopram [Moles/volume] in Serum or Plasma

+∞

21.72

1.3

0.0

185.20

—

nmol/l

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

252

895

1.99

21.71

1.3

1.4

11.67

11.86

umol/l

0.18

238

873

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1389

7396

1.34

21.66

2.6

2.7

127.67

163.60

ng/l

3.20

1240

6660

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

633

2922

1.54

21.64

1.4

1.5

—

(3005570) Glucose [Moles/volume] in Urine

284

1057

1.90

21.38

2.0

1.7

—

40.22

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

176

3.36

21.13

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

2475

21075

0.81

21.12

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

156

3.52

21.01

1.4

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3076

25588

0.82

20.80

3.6

3.5

21.70

21.86

0.20

1139

10580

(3023419) Bacteria identified in Sputum by Culture

336

1331

1.79

20.79

2.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

514

2286

1.59

20.68

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

221

763

2.05

20.60

2.8

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

140

400

2.47

20.38

1.4

1.2

110.67

112.27

0.27

127

358

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

467

2040

1.62

20.23

1.1

52.49

987.82

iu/ml

0.88

105

469

(3010015) Selenium [Moles/volume] in Serum or Plasma

5.37

20.15

2.3

1.8

1.33

1.30

umol/l

0.24

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

108

272

2.80

20.09

2.2

3.1

28.39

28.33

umol/l

0.01

221

(3039443) Prostate specific Ag panel - Serum or Plasma

228

3005

0.53

20.06

1.4

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

219

763

2.03

19.94

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

4.47

19.85

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

139

3.60

19.74

1.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

251

922

1.92

19.69

1.5

1.3

1.32

1.37

nmol/l

0.27

225

830

(40757494) Bilirubin.total [Moles/volume] in Blood

148

442

2.36

19.62

2.2

18.17

36.26

umol/l

0.72

(3013247) Albumin in CSF/Albumin in Serum or Plasma

109

280

2.74

19.57

1.1

5.70

6.74

mg/g

1.35

103

265

(4094501) Cardiovascular stress test using bicycle ergometer

686

3294

1.48

19.47

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

241

877

1.94

19.44

1.1

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

165

523

2.23

19.11

1.2

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

585

2736

1.52

18.88

1.4

1.5

107.67

111.06

u/ml

0.36

120

632

(3027923) C peptide [Moles/volume] in Serum or Plasma

167

536

2.20

18.78

1.7

1.53

1.21

nmol/l

2.51

124

438

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

456

2022

1.60

18.62

1.5

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

138

410

2.37

18.54

1.2

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

138

410

2.37

18.54

1.2

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

256

971

1.86

18.28

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

256

971

1.86

18.28

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

256

972

1.86

18.22

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

266

1024

1.84

18.14

1.2

1.3

146.38

224.58

titre

1.02

177

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

265

1019

1.84

18.13

1.2

1.3

167.50

244.55

titre

0.27

(3010838) Calcium [Moles/time] in 24 hour Urine

483

2186

1.56

18.10

1.7

2.0

5.45

mmol/24h

0.00

439

1988

(3006922) Hepatitis E virus Ab [Presence] in Serum

233

860

1.91

18.07

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

253

962

1.86

17.94

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

253

962

1.86

17.94

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

253

963

1.86

17.88

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

128

375

2.41

17.75

1.1

1.56

3.29

u/ml

0.64

211

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

414

1815

1.61

17.74

1.0

0.52

0.43

u/ml

0.19

115

438

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

477

2163

1.56

17.73

1.2

3.12

3.79

u/ml

1.21

199

1015

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

143

3.40

17.72

1.4

1.3

0.39

0.26

nmol/l

0.62

100

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

160

518

2.18

17.66

1.2

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

612

2937

1.48

17.46

2.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

217

795

1.93

17.23

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

175

593

2.08

17.23

1.6

1.8

130.06

138.93

0.93

166

559

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

171

3.13

17.20

1.8

1.3

53.56

66.41

ng/l

0.28

129

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

216

791

1.93

17.18

1.1

—

(3049717) Cytology report of Urine Cyto stain

639

3104

1.46

17.15

2.2

2.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

397

1742

1.61

16.97

1.6

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

237

902

1.86

16.79

3.0

2.6

798.32

628.08

e6/l

6.18

229

882

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2168

18307

0.82

16.79

1.6

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

153

499

2.16

16.61

1.9

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

249

966

1.82

16.61

1.2

70.75

43.68

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

250

973

1.81

16.51

6.2

4.7

7.14

7.13

mmol/l

0.02

204

783

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

641

3143

1.45

16.40

2.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

131

405

2.28

16.17

1.1

98.31

90.73

1.96

193

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

209

2.83

16.07

1.1

1.34

2.39

u/ml

0.41

153

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

179

2.99

15.99

1.4

1.5

5.54

6.26

nmol/l

0.67

173

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

243

948

1.81

15.95

1.2

75.57

66.11

u/ml

0.19

(4146454) Self-monitoring of blood glucose

250

984

1.79

15.94

2.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1004

5342

1.33

15.76

11.0

10.5

—

(3001556) Androgen free Index in Serum or Plasma

137

3.29

15.70

1.3

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

243

953

1.80

15.68

1.2

61.26

46.33

u/ml

0.38

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

132

416

2.24

15.60

1.1

2475.47

496.19

ng/l

0.45

116

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

132

416

2.24

15.60

1.2

1.1

119.08

108.14

2.26

120

373

(3002079) Sodium [Moles/time] in 24 hour Urine

160

545

2.07

15.60

1.2

148.43

159.83

mmol/24h

1.12

160

545

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2271

18937

0.83

15.36

2.5

2.6

0.64

0.73

ug/l

2.00

1437

10487

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

399

1802

1.57

15.17

1.6

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

191

703

1.92

15.04

1.6

6.82

6.22

u/l

0.23

146

585

(3008116) Ketones [Moles/volume] in Urine by Test strip

156

3.07

14.97

1.8

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

501

2388

1.48

14.86

1.6

1.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

126

398

2.23

14.84

1.1

104.06

90.52

2.98

194

(3000475) Leukocytes [#/volume] in Synovial fluid

546

2656

1.46

14.62

1.6

1.7

14335.96

12361.95

e6/l

0.27

409

1968

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

231

913

1.79

14.57

1.2

8.45

13.44

u/ml

0.29

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

271

2.50

14.48

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

474

2247

1.49

14.45

1.2

2.45

3.44

u/ml

1.07

152

815

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

215

836

1.82

14.32

4.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

232

2.61

14.21

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

387

1763

1.55

14.20

1.2

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

264

1093

1.71

14.20

1.4

2.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

220

2.66

14.19

1.2

481.49

309.33

pmol/l

0.41

165

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

220

866

1.79

14.09

2.8

2.6

551.40

499.53

e6/l

0.91

183

725

(3011841) English Walnut IgE Ab [Units/volume] in Serum

108

3.46

14.03

1.0

0.21

1.49

u/ml

0.72

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

235

2.58

13.87

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

511

2480

1.46

13.87

1.6

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

993

5383

1.31

13.70

1.5

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

823

4345

1.34

13.65

1.6

0.82

5.25

iu/ml

0.59

157

883

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

287

1229

1.65

13.63

3.3

5.4

108.89

136.12

u/ml

0.25

449

(3011412) CD3 cells [#/volume] in Blood

281

1198

1.66

13.57

2.6

2.4

1.39

1.14

e9/l

4.77

245

1070

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

130

433

2.12

13.50

1.6

1.9

134.55

163.17

3.57

122

407

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

222

2.60

13.48

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

440

2086

1.49

13.45

1.1

124.10

118.17

3.20

397

1904

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

116

371

2.20

13.32

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

188

2.73

13.20

1.3

1.4

64.28

57.85

mu/l

0.13

141

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

454

2175

1.48

13.19

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

179

678

1.86

13.00

1.2

1.3

96.70

84.59

u/l

0.50

157

599

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

212

847

1.77

12.96

2.9

2.6

0.22

e9/l

0.06

181

725

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

252

2.46

12.94

1.1

—

(3020491) Glucose [Moles/volume] in Blood

221

897

1.74

12.81

1.6

6.89

6.32

mmol/l

1.73

169

649

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

283

1230

1.62

12.71

8.3

6.6

11.23

11.12

mg/l

0.15

262

1152

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

105

3.35

12.70

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

316

1412

1.58

12.67

1.6

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

174

659

1.86

12.66

1.2

1.3

27.23

22.31

u/l

0.42

151

573

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1322

7510

1.25

12.56

2.7

3.5

54.18

48.26

u/ml

0.10

1279

7288

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

235

2.49

12.51

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

240

2.47

12.43

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

262

1127

1.64

12.28

2.1

41.32

38.41

2.50

257

1109

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

104

3.32

12.26

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

126

3.07

12.21

1.0

0.01

0.22

u/ml

1.11

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

147

533

1.94

12.19

1.9

2.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

500

2480

1.43

12.15

1.2

1.3

2.97

3.91

ug/l

2.10

451

2221

(3033923) Metanephrine [Moles/time] in 24 hour Urine

194

2.61

12.00

1.2

1.1

0.77

7.37

umol/24h

0.49

106

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

143

2.91

11.93

1.4

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

327

1495

1.54

11.90

1.7

1.6

42.05

36.45

iu/ml

0.18

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

498

2481

1.42

11.82

2.3

2.5

98.00

95.86

ug/min

0.04

314

1601

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

440

2146

1.45

11.72

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

111

3.17

11.69

1.0

0.14

1.93

u/ml

0.51

(3029075) Extractable nuclear Ab panel - Serum

105

341

2.17

11.68

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

288

1289

1.58

11.52

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

21.10

11.48

1.0

—

mmol/l

—

(3045424) Erythrocytes [Presence] in Urine

417

2023

1.46

11.43

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

324

1493

1.53

11.40

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

235

1003

1.65

11.39

1.4

2.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

167

2.70

11.36

1.0

79.83

82.78

ug/l

0.19

134

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

265

1168

1.60

11.31

1.4

1.3

188.78

211.50

pmol/l

0.23

265

1168

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

566

2906

1.38

11.29

1.3

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

213

890

1.69

11.20

2.7

2.8

—

(3002619) Bacteria identified in Specimen by Culture

177

2.63

11.13

1.2

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

153

581

1.86

11.11

1.2

22.43

22.18

u/l

0.02

138

541

(3001964) Herpes simplex virus Ag [Presence] in Specimen

109

368

2.09

11.03

1.8

1.5

—

(4034850) Laboratory test

708

3777

1.33

11.02

10.0

7.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

152

582

1.84

10.77

1.2

85.97

81.27

u/l

0.24

137

542

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

729

3919

1.32

10.76

6.0

5.0

1.91

1.63

4.57

692

3672

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4081

31745

0.88

10.71

4.0

1.69

2.46

ug/l

4.34

3654

29354

(1175426) CD3 cells/100 lymphocytes in Blood

223

962

1.64

10.42

2.2

2.0

76.63

73.03

4.56

211

932

(3051611) Lipemic interference index of Serum or Plasma

249

1106

1.59

10.34

3.1

3.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

201

2.45

10.33

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

105

359

2.06

10.32

2.7

1.8

130.16

240.65

e6/l

0.92

168

(3047181) Lactate [Moles/volume] in Blood

601

3167

1.34

10.21

6.7

5.7

1.31

1.24

mmol/l

0.81

536

2801

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

295

1370

1.52

10.08

1.7

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

621

3300

1.33

9.97

3.3

1.41

1.42

mg/l

0.08

568

3083

(3008757) Leukocyte morphology finding [Identifier] in Blood

239

1062

1.59

9.93

2.5

3.9

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

3.39

9.87

1.0

1.43

0.35

u/ml

0.35

(3007930) Methemoglobin/Hemoglobin.total in Blood

708

3842

1.30

9.80

6.1

5.0

0.88

0.90

1.16

675

3607

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

160

642

1.76

9.78

1.2

15.50

21.14

u/ml

0.17

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

109

2.97

9.74

1.1

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

4.19

9.67

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

115

417

1.94

9.65

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

3.34

9.43

1.1

0.27

0.41

u/ml

0.36

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

525

2745

1.35

9.42

6.1

6.5

1862.14

1505.78

iu/ml

0.14

438

(3044941) Cell count panel - Synovial fluid

348

1696

1.45

9.41

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

279

1303

1.51

9.33

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

407

2045

1.41

9.32

3.0

296.24

4098.07

u/ml

0.90

106

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

3.57

9.28

1.0

8.16

22.50

u/ml

1.33

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

216

954

1.60

9.24

2.2

2.0

12.76

15.03

3.37

209

931

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

203

884

1.62

9.20

2.3

2.0

—

(3003694) ABO and Rh group [Type] in Blood

6526

42718

1.10

9.19

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

17.58

9.16

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

115

425

1.91

9.16

2.3

2.0

—

(3051651) Icteric interference index of Serum or Plasma

155

629

1.74

9.15

3.5

3.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

226

1013

1.57

9.10

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

199

866

1.62

9.06

1.4

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

199

866

1.62

9.06

1.4

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

199

866

1.62

9.06

1.4

1.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.42

8.99

2.2

2.1

—

(3044927) Protein electrophoresis panel - Urine

180

766

1.66

8.95

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

224

1007

1.57

8.92

1.3

1.5

76865.96

81568.52

e6/l

0.05

162

664

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

208

2.30

8.82

1.1

—

(3042631) Mycobacterium sp identified in Specimen

253

1178

1.52

8.62

2.7

2.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

197

869

1.60

8.52

1.1

1.2

1.05

1.06

ratio

0.55

308

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

577

3107

1.31

8.52

3.8

3.5

0.34

0.35

u/ml

0.03

329

1728

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

120

462

1.83

8.47

1.1

1.0

8.42

13.38

u/ml

1.85

279

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

119

2.72

8.40

1.0

0.05

0.06

u/ml

0.04

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

3.32

8.37

1.0

0.16

1.50

u/ml

0.84

(3002523) Influenza virus A Ag [Presence] in Specimen

502

2658

1.33

8.34

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.23

8.29

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

124

2.67

8.28

1.0

0.31

0.21

u/ml

0.11

(3030313) Adrenal Ab [Titer] in Serum

116

2.73

8.28

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

357

1793

1.41

8.25

1.6

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

502

2663

1.33

8.24

3.0

3.6

28.16

45.98

mg/l

2.85

397

2197

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

357

1794

1.40

8.23

1.6

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

503

2670

1.33

8.23

3.0

3.6

40.41

50.07

mg/l

1.62

397

2205

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

490

2592

1.34

8.21

2.9

3.6

1.85

2.04

ratio

0.15

210

(3017569) Oxygen content in Arterial blood

347

1.95

8.20

1.9

2.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1501

12299

0.85

8.18

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

500

2657

1.33

8.12

1.1

—

(3004451) EKG impression Narrative

108

408

1.86

8.11

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

246

1155

1.50

8.09

1.8

1.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

123

486

1.78

8.01

2.7

2.1

8.45

10.17

1.45

115

449

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

313

1545

1.43

7.99

1.1

97.16

96.35

0.19

296

1464

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.94

7.97

2.0

1.9

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

126

503

1.76

7.93

1.2

63.08

102.65

titre

0.42

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

247

1169

1.49

7.84

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

271

2.05

7.81

1.1

1.2

90.33

88.98

0.08

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

1.01

1.65

mg/l

0.45

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

3.23

1.50

mg/l

0.77

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

2.47

1.48

mg/l

0.94

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

3.44

2.72

mg/l

0.19

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

1.99

2.11

mg/l

0.06

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

3.50

4.51

mg/l

0.41

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

2.47

3.21

mg/l

0.32

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

3.39

1.42

mg/l

1.13

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

100

2.81

7.79

1.5

0.97

0.80

mg/l

0.14

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

104

2.77

7.79

1.5

2.24

1.90

mg/l

0.14

(3044242) Glucose [Moles/volume] in Arterial blood

356

1.90

7.65

2.2

1.9

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

283

2.02

7.64

1.1

1.3

108.65

104.79

0.53

265

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

289

2.00

7.56

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.10

7.55

1.1

14.72

13.97

nmol/l

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

307

1528

1.42

7.52

2.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.34

7.47

1.2

1.6

40.29

29.09

0.53

(3051593) INR in Capillary blood by Coagulation assay

305

1.96

7.46

5.6

13.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

109

427

1.80

7.34

1.0

1.1

—

(3000012) Reticulocyte production index

249

1198

1.47

7.32

2.0

2.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

618

3433

1.27

7.26

1.4

99.89

120.74

pmol/l

0.81

603

3357

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

195

2.20

7.23

2.8

2.5

—

(3021788) Differential panel - Synovial fluid

392

2049

1.35

7.17

1.5

—

(3013466) aPTT in Blood by Coagulation assay

3.04

7.14

1.0

1.1

34.96

38.19

1.88

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

276

1.99

7.14

1.1

1.2

80.50

77.71

0.14

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

118

478

1.74

7.12

2.6

2.0

28.05

29.64

0.66

111

453

(3014148) Varicella zoster virus Ab [Titer] in Serum

402

2113

1.34

7.10

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

204

949

1.52

7.08

1.0

1.1

0.51

1.50

u/ml

1.63

292

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

106

419

1.78

6.96

1.4

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

106

419

1.78

6.96

1.4

2.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.10

6.92

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

147

638

1.62

6.89

1.0

1.1

102.58

96.43

1.52

115

513

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

168

754

1.57

6.86

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

152

667

1.61

6.82

1.1

1654.75

1410.89

miu/ml

1.59

152

667

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

107

427

1.76

6.82

1.4

2.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

129

2.45

6.80

1.0

1.3

51.71

62.89

0.54

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

234

2.05

6.73

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

135

578

1.65

6.69

2.1

2.6

24.47

337.91

ug/l

1.71

126

554

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

6.03

6.63

1.0

0.04

0.21

u/ml

—

(3010503) CD19 cells [#/volume] in Blood

165

744

1.56

6.62

2.6

0.16

0.39

e9/l

1.29

158

731

(3033942) Copper [Moles/time] in 24 hour Urine

3.60

6.59

1.1

1.2

0.38

1.02

umol/24h

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

161

723

1.57

6.58

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

140

2.36

6.57

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

198

933

1.50

6.51

1.0

2.89

2.63

u/ml

0.03

221

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

201

951

1.49

6.48

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

214

2.07

6.47

1.2

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.17

6.44

1.1

1.6

12.94

15.17

0.13

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

135

584

1.63

6.44

1.3

1.5

18.74

23.41

u/ml

0.54

102

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

112

461

1.71

6.44

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

131

563

1.64

6.41

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

165

1750

0.66

6.41

1.2

—

(3028433) Virus identified in Specimen by Culture

363

1.80

6.40

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

108

2.54

6.35

2.6

2.8

0.91

1.22

mmol/l

0.33

(40768441) Liver Pathology biopsy report

194

917

1.49

6.30

1.5

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

161

2.23

6.28

1.6

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

161

732

1.55

6.26

1.1

—

(3000330) Specific gravity of Urine by Test strip

932

5501

1.20

6.25

3.3

3.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

168

2.18

6.07

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

275

1.89

5.96

1.0

0.40

0.86

u/ml

1.64

247

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

254

1279

1.40

5.93

2.5

3.4

4.81

9.04

nmol/l

0.47

239

1238

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

394

1.73

5.88

3.2

3.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

388

2090

1.31

5.87

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

180

2.11

5.86

1.0

0.15

0.09

u/ml

0.17

126

(3035947) Staphylolysin Ab [Units/volume] in Serum

122

528

1.63

5.85

1.2

1.1

3.38

4.02

iu/ml

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

117

2.41

5.85

1.0

0.02

0.54

u/ml

0.90

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

165

768

1.51

5.80

2.5

3.5

104.54

134.12

nmol/l

0.60

158

756

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

284

1.86

5.73

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

284

1.86

5.73

1.2

1.1

—

(3037756) Immunofixation for Serum or Plasma

336

1780

1.33

5.72

1.5

1.8

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

110

2.43

5.69

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

285

1.85

5.67

1.2

1.1

—

(3019977) pH of Arterial blood

107

454

1.66

5.57

2.8

2.1

7.43

7.42

0.09

159

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.17

5.54

1.0

1.4

0.67

1.67

0.93

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

107

456

1.65

5.48

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

157

2.15

5.48

1.5

512127.74

282864.33

nmol/l

0.25

140

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

224

1.95

5.46

1.3

1.6

0.40

ug/l

0.03

152

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

116

507

1.61

5.39

1.6

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

353

1.74

5.34

1.6

8.46

8.81

ug/l

0.43

353

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

301

1589

1.34

5.29

1.2

26.80

30.54

u/l

0.25

261

1394

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

119

2.31

5.24

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

385

2106

1.29

5.24

1.1

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

115

2.33

5.21

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

6.53

5.20

1.1

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

116

513

1.59

5.16

1.6

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

280

1.81

5.11

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

280

1.81

5.11

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

280

1.81

5.11

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

280

1.81

5.11

1.2

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.88

5.10

1.0

0.14

0.94

u/ml

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.88

5.10

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

156

741

1.48

5.04

3.5

2.8

42.42

38.44

1.57

395

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

246

1.86

5.02

3.1

2.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

246

1.86

5.02

3.1

2.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

113

2.30

4.98

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

2.39

4.97

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.58

4.94

1.0

6.89

9.40

u/ml

0.31

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

124

564

1.55

4.91

1.4

2.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

108

477

1.59

4.86

3.2

3.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

318

1715

1.31

4.85

2.4

3.5

1.18

1.58

1.54

286

1559

(3024263) Appearance of Synovial fluid

122

556

1.55

4.80

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

220

1.89

4.79

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

579

1.53

4.78

1.6

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

129

596

1.52

4.78

2.4

2.5

181.73

145.24

au/ml

0.29

(3017354) Segmented neutrophils/100 leukocytes in Blood

200

1007

1.40

4.77

2.2

3.5

55.14

56.57

0.42

173

880

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

120

2.23

4.76

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

123

563

1.54

4.76

1.4

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

203

1028

1.39

4.69

1.4

1.6

35.43

33.79

0.24

124

660

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

255

1342

1.34

4.64

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.18

4.63

1.3

1.8

43.47

53.43

umol/l

0.65

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

237

1237

1.35

4.56

1.7

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

237

1238

1.35

4.54

1.7

1.6

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

4.52

1.0

0.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.32

4.42

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

432

1.58

4.27

1.2

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

184

1.91

4.26

1.5

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

221

1155

1.35

4.25

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

108

2.21

4.24

1.1

1.66

5.13

umol/24h

0.52

108

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

141

684

1.45

4.18

7.8

5.4

283.28

754.07

u/ml

0.57

119

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.60

4.17

1.1

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

599

4989

0.84

4.13

1.7

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.27

4.10

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.61

4.04

1.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

178

1.90

4.02

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

2.25

4.01

1.1

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

125

598

1.47

4.00

1.5

2.71

2.87

u/field

0.08

434

(3010370) Gastrin [Moles/volume] in Serum or Plasma

159

1.95

3.97

1.9

1.7

141.51

45.83

pmol/l

0.45

136

(3036603) Volume of Urine

161

810

1.40

3.94

1.4

1.7

2247.68

1978.99

0.91

155

792

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

105

486

1.52

3.94

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

215

1.80

3.93

2.4

2.8

25.24

50.15

mg/l

0.87

(3015076) Soybean IgE Ab [Units/volume] in Serum

170

864

1.39

3.92

1.0

0.34

0.41

u/ml

0.23

193

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

325

2855

0.80

3.87

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

360

2035

1.25

3.86

3.1

3.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

186

963

1.36

3.84

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

142

1.98

3.81

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

152

1.94

3.79

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

197

1032

1.34

3.78

1.3

1.4

28.74

32.97

nmol/l

1.28

175

970

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

100

2.18

3.76

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

523

3083

1.20

3.73

1.3

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.04

3.67

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.73

3.64

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

133

657

1.43

3.64

3.1

3.0

8.12

8.07

mg/l

0.03

100

541

(3013166) Neutrophils/100 leukocytes in Synovial fluid

317

1.62

3.62

1.2

1.5

41.72

52.72

1.60

273

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

106

502

1.49

3.60

1.2

—

(3006462) Nitrate [Presence] in Urine

115

557

1.45

3.51

3.0

2.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

108

2.08

3.50

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

293

1.63

3.49

1.2

—

(3016228) CD19 cells/100 cells in Blood

105

502

1.47

3.43

1.7

2.0

8.17

8.70

0.22

100

495

(3016750) Collection duration of Urine

126

624

1.42

3.43

2.1

2.4

511.26

493.67

min

1.52

100

508

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

141

714

1.39

3.38

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

226

1.71

3.38

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

164

1.84

3.37

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

102

487

1.47

3.36

2.3

2.0

90.35

74.65

ug/min

0.12

107

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.31

3.35

1.0

1.1

8.54

11.75

u/l

0.37

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

152

782

1.37

3.32

1.2

—

(40768793) Breast Pathology biopsy report

506

3018

1.18

3.22

1.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.47

3.21

1.6

0.85

0.63

umol/l

0.60

(3033799) Differential panel - Peritoneal fluid

284

1.61

3.19

1.8

1.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

199

1.73

3.16

1.3

24.88

28.54

g/l

0.78

159

(3036071) Salmonella sp Ab [Titer] in Serum

100

483

1.46

3.14

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.20

3.14

1.5

1.2

319.60

325.68

umol/24h

0.06

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

104

2.03

3.10

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

2.04

3.04

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

3.52

3.02

1.0

4.43

0.36

u/ml

—

(21494814) CD8 cells/100 lymphocytes in Specimen

101

495

1.44

2.96

1.7

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

509

4163

0.86

2.93

1.4

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

356

2081

1.21

2.88

3.3

2.6

1.50

mmol/l

0.02

349

2037

(3020876) Protein [Mass/time] in 24 hour Urine

199

1092

1.28

2.85

2.2

2.6

1.34

1.40

g/24h

0.11

602

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

107

535

1.41

2.83

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

490

1.42

2.78

3.6

8.0

2180.55

2889.04

mg/l

0.12

357

(40761995) Spermatozoa Progressive [#/volume] in Semen

638

0.65

2.77

3.6

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

637

0.65

2.75

7.1

6.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

135

708

1.34

2.69

37.6

35.9

7.60

7.40

ug/l

0.54

123

652

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

153

819

1.32

2.66

2.1

1.7

—

(3000285) Sodium [Moles/volume] in Blood

126

1.84

2.64

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

299

1.53

2.63

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

158

851

1.31

2.63

1.9

1.7

2.47

1.86

u/field

0.56

383

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

432

1.43

2.60

2.4

1.5

432.17

37340.09

u/ml

0.96

(3000034) Microalbumin [Mass/volume] in Urine

179

982

1.28

2.60

3.0

2.9

35.63

61.54

mg/l

0.97

123

687

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.26

2.59

1.3

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

358

1.47

2.57

2.4

1.7

8739.24

4879.25

e6/l

0.23

241

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

318

1.50

2.57

2.3

1.7

18398.73

17087.58

e6/l

0.03

162

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

143

1.77

2.56

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

2.20

2.55

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

4.92

2.54

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

1.94

2.52

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

314

1.50

2.51

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

944

0.73

2.48

1.2

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.69

2.48

1.1

—

(3039000) Anion gap in Blood

366

2181

1.18

2.45

9.0

6.9

11.48

11.09

mmol/l

1.38

336

1959

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.26

2.45

1.5

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

252

1450

1.22

2.45

1.5

1.6

56.78

54.34

0.41

153

979

(3018572) Chloride [Moles/volume] in Blood

366

2182

1.18

2.44

9.0

6.9

104.48

105.48

mmol/l

3.47

336

1960

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

368

1.45

2.44

1.4

1.8

—

547.00

iu/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

116

605

1.35

2.44

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

301

1764

1.20

2.43

1.2

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

156

1.71

2.43

6.1

6.9

63.79

73.77

1.31

124

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

318

1880

1.19

2.35

2.4

2.5

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

5.27

2.34

1.2

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

826

6436

0.90

2.32

1.9

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

191

1.62

2.31

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

200

1736

0.81

2.30

1.5

1.6

7.94

7.53

mmol/l

2.03

192

1660

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

385

1.43

2.29

4.4

3.9

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.86

2.27

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.12

2.25

1.1

1.0

—

(3017704) Immunofixation for Urine

469

1.38

2.25

1.4

1.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1719

11275

1.08

2.23

3.3

4.4

14.56

28.08

ug/l

1.82

1318

8825

(3015350) Toxocara sp Ab [Presence] in Serum

4.10

2.22

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.09

2.18

1.3

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

200

1.58

2.17

4.4

5.2

57.59

41.72

ug/min

0.48

165

(3006567) Chloride [Moles/time] in 24 hour Urine

3.16

2.16

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.29

2.13

1.6

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

174

1.62

2.11

2.6

2.7

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

2.10

0.0

2.6

—

27.90

—

(3015183) Erythrocyte sedimentation rate

142

781

1.28

2.10

1.3

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.01

2.05

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

382

1.40

2.05

1.6

1.8

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.24

2.04

1.3

1.53

1.40

0.71

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

466

1.36

2.04

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

466

1.36

2.04

1.4

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.02

2.03

1.1

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

165

1.62

2.03

2.4

2.5

7.20

7.68

mmol/l

0.26

(3010375) cycloSPORINE [Mass/volume] in Blood

118

640

1.30

1.96

28.7

27.9

116.12

119.87

ug/l

0.24

536

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.52

1.96

1.0

1.1

—

(3022670) pH of Venous cord blood

2.88

1.96

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

2.88

1.96

1.1

69.80

70.95

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

462

0.67

1.90

1.0

1.2

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

3.84

1.87

1.5

1.0

—

27.15

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.75

1.86

1.1

3.6

4.14

2.25

mu/l

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

2.96

1.84

1.1

46.41

36.48

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

382

2349

1.15

1.80

1.3

1.4

6.97

6.91

mmol/l

0.16

351

2089

(3008536) Aspergillus sp Ab [Presence] in Serum

228

1.48

1.78

1.7

2.6

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.99

1.77

1.2

—

22.42

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.81

1.75

1.1

—

(3004775) Volume in Urine collected for unspecified duration

148

840

1.24

1.74

2.2

2.5

698.35

672.72

0.27

118

619

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

185

1076

1.21

1.73

1.6

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

190

1.52

1.71

2.8

2.0

—

(3034614) HLA Ag [Interpretation]

2.28

1.71

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.34

1.66

6.5

5.5

0.26

0.24

mmol/l

0.08

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.80

1.66

1.9

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

222

1.46

1.61

1.8

1.2

10.96

14.87

g/l

1.85

178

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

111

617

1.27

1.59

1.1

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

112

0.44

1.59

1.1

1.4

67.29

68.20

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

110

1.66

1.58

1.4

2.7

—

(3052592) Norovirus Ag [Presence] in Stool

160

1.54

1.57

1.0

1.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.56

1.57

1.0

—

(3019174) dRVVT (LA screen)

116

1.64

1.56

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

212

1.46

1.56

2.1

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

564

0.73

1.55

1.2

1.3

13.74

14.48

u/l

0.14

518

(3035933) Granulocytes/100 leukocytes in Blood

397

1.33

1.55

1.2

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

423

1.31

1.52

2.1

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

308

1.37

1.51

1.3

1.2

39.75

41.32

g/l

0.42

175

(3041672) Baker's yeast Ab [Presence] in Serum

1.87

1.51

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.91

1.51

1.2

1.3

21.19

21.57

mmol/l

—

(3044009) aPTT.lupus sensitive (LA screen)

123

1.60

1.49

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

133

762

1.23

1.48

1.2

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.78

1.47

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.81

1.46

1.1

1.0

—

(3012565) Volume of 24 hour Urine

102

569

1.26

1.45

1.7

2.2

1863.86

1996.60

0.72

521

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.81

1.41

1.2

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.20

1.40

1.8

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.65

1.39

1.3

2.9

2.20

656.93

pmol/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.72

1.38

1.1

0.11

0.87

u/ml

0.90

(3042733) HLA Ab [Presence] in Serum

548

1.26

1.38

4.5

5.4

—

(3024316) Viscosity of Plasma

1.88

1.38

2.5

1.5

1.77

1.39

mpas

—

(3034426) Prothrombin time (PT)

517

1.27

1.37

1.1

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

543

1.26

1.36

1.3

1.5

5.94

4.40

0.30

138

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

158

931

1.19

1.36

1.3

1.4

5.69

5.42

mmol/l

1.21

148

885

(3038515) Glucose [Moles/volume] in Venous blood

319

1984

1.13

1.35

3.5

2.6

7.18

7.40

mmol/l

0.74

312

1950

(3011325) HIV 1+2 Ab [Presence] in Serum

1.76

1.35

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

219

1.41

1.35

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

167

1.47

1.33

2.3

2.4

24.16

22.95

mg/l

0.22

155

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

141

1182

0.84

1.28

1.2

1.3

1.54

g/l

0.14

141

1182

(3006598) pH of Arterial cord blood

2.34

1.28

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.48

1.24

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.73

1.23

1.0

1.1

0.95

23.23

u/ml

0.47

(3035285) Chloride [Moles/volume] in Venous blood

185

1118

1.16

1.21

2.5

2.0

105.57

105.49

mmol/l

0.09

185

1106

(3012989) Citrate [Moles/time] in 24 hour Urine

2.16

1.19

1.1

1.3

1.92

2.13

mmol/24h

—

(3041354) Potassium [Moles/volume] in Venous blood

185

1120

1.16

1.19

2.5

2.0

4.00

4.01

mmol/l

0.10

185

1108

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

628

4085

1.08

1.15

3.3

3.9

268.82

2214.42

u/ml

2.07

529

3529

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.67

1.15

1.3

1.0

12.60

4.18

u/ml

0.29

(3033705) Calcium.ionized [Moles/volume] in Venous blood

182

1104

1.16

1.15

2.5

2.0

—

(3022475) Manganese [Moles/volume] in Blood

1.62

1.15

1.0

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

2.08

1.15

1.4

1.3

—

(3018133) Calcium [Moles/volume] in Urine

191

1.40

1.14

1.3

1.9

2.66

2.75

mmol/l

0.09

169

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

111

646

1.21

1.13

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

8132

58168

0.97

1.13

2.7

2.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.73

1.10

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.66

1.09

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

218

1.36

1.06

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

419

2691

1.10

1.06

3.6

2.8

26.22

26.49

mg/l

0.04

232

1745

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.55

1.05

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

203

1252

1.14

1.05

3.2

2.8

0.77

0.82

nmol/l

1.12

144

956

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

347

2210

1.11

1.04

2.8

3.8

755.32

687.83

u/ml

0.06

310

2026

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.64

1.04

1.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.98

1.04

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

165

1.41

1.04

2.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

968

7205

0.94

1.04

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.34

1.03

3.6

4.8

—

(40768446) Kidney Pathology biopsy report

102

597

1.20

1.01

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

166

1.40

1.01

9.5

9.3

5.51

5.35

mmol/l

0.10

166

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.05

1.00

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.67

1.00

7.4

8.0

382.00

307.70

e6/l

—

(3044007) Cell count panel - Peritoneal fluid

295

1.29

0.99

2.2

1.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.58

0.98

1.3

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

115

684

1.18

0.97

1.2

1.3

—

(3035880) pH of Pleural fluid

435

0.78

0.97

1.4

1.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.34

0.96

1.5

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

254

1.30

0.94

3.6

2.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.22

0.93

1.2

1.70

1.95

mg/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

715

5348

0.94

0.93

1.4

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

110

1.47

0.93

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

235

1479

1.12

0.91

1.4

8.92

7.66

mmol/l

3.54

230

1435

(3009015) Lactate [Moles/volume] in Synovial fluid

111

1.46

0.89

1.2

1.3

4.95

6.48

mmol/l

0.76

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.58

0.89

2.4

5.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1462

10711

0.96

0.89

1.4

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.64

0.88

3.5

2.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

104

620

1.18

0.88

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

408

2647

1.08

0.87

4.6

3.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

1.46

0.86

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.66

0.86

1.2

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

219

0.71

0.85

7.0

7.1

—

(3016135) IgD [Mass/volume] in Serum

1.76

0.82

1.0

2.5

35.36

170.41

mg/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.57

0.82

1.1

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.57

0.82

1.0

0.19

0.06

u/ml

—

(3020650) Glucose [Presence] in Urine

381

1.22

0.80

1.4

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

163

1014

1.13

0.80

1.9

2.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.51

0.80

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.59

0.79

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.55

0.79

5.1

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.83

0.78

1.0

1.1

2.00

3.22

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

306

1.24

0.78

1.9

29.51

30.01

u/l

0.01

283

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

163

1.34

0.78

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.20

0.76

7.6

3.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

597

1.17

0.76

2.2

1.9

8.05

9.80

mg/l

2.60

483

(4212803) Bone marrow aspirate examination

1.49

0.76

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

110

1.41

0.74

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.07

0.74

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

102

0.62

0.71

1.2

1.5

—

(46235168) Fasting glucose [Moles/volume] in Blood

227

0.74

0.71

3.7

1.2

7.67

6.98

mmol/l

0.42

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

204

1580

0.91

0.69

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

695

4640

1.05

0.69

1.4

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.53

0.68

1.0

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

106

1.39

0.68

1.0

0.24

1.14

u/ml

0.48

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.85

0.67

1.4

2.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

211

1.27

0.67

1.5

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.61

0.67

11.6

9.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.64

0.67

1.6

1.0

—

(40768806) Pleura Pathology biopsy report

106

850

0.88

0.66

1.6

1.5

—

(3026480) Teichoate Ab [Titer] in Serum

1.44

0.66

1.2

1.0

—

2.67

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.44

0.66

2.7

5.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

462

1.17

0.66

1.9

1.6

137.58

125.06

au/ml

0.09

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

138

866

1.12

0.63

5.7

7.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

135

847

1.12

0.63

1.6

1.8

3.36

3.60

mg/l

0.24

127

817

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.53

0.61

1.1

139.00

124.43

ug/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

307

0.80

0.61

7.1

8.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

279

1.21

0.59

5.0

5.6

—

(3013762) Body weight Measured

1.51

0.58

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

104

1.35

0.57

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

185

1.25

0.57

1.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

236

1.22

0.56

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

280

0.80

0.56

7.1

7.7

—

(3024932) HLA-DR beta [Type]

543

1.14

0.55

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

135

1051

0.90

0.55

1.5

1.4

34.69

34.61

g/l

0.02

124

965

(4035726) Immunohistochemistry procedure

1603

10956

1.03

0.55

1.4

—

(3045142) Bone marrow Pathology biopsy report

161

1242

0.91

0.55

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

611

0.87

0.53

2.5

3.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

335

1.18

0.53

1.6

2.5

97.44

101.33

ng/l

0.07

172

(3024471) HLA-A [Type]

553

1.13

0.51

1.0

—

(40758292) HTLV I+II Ab panel - Serum

260

0.81

0.50

1.4

—

(4281824) Cell count and differential, peritoneal fluid

201

1522

0.93

0.47

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

826

5603

1.04

0.47

1.4

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

674

4560

1.04

0.45

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

824

5598

1.04

0.44

1.4

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

103

1.30

0.44

1.3

—

(3022689) Creatine [Moles/volume] in Urine

388

1.14

0.44

1.5

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.60

0.43

8.2

10.5

—

(3005033) Fetal Nuchal fold Thickness US

671

4546

1.04

0.42

1.4

1.5

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.42

0.0

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.42

0.0

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

822

5595

1.03

0.41

1.4

1.5

—

(3048879) Bone marrow aspiration report

279

1.16

0.40

1.6

2.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.46

0.40

1.0

—

(21494434) Karyotype in Bone marrow

119

909

0.92

0.38

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.29

0.37

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

817

5575

1.03

0.37

1.4

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.45

0.36

1.2

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.31

0.36

1.3

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

119

0.77

0.36

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.41

0.35

1.0

1.1

241.00

274.93

nmol/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

155

1018

1.07

0.34

1.0

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.26

0.33

1.0

1.1

28.19

23.42

u/l

0.29

(40768795) Lymph node Pathology biopsy report

179

1336

0.94

0.32

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

711

0.92

0.32

1.3

814.95

421.67

u/l

0.70

680

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

206

1.16

0.32

1.1

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

127

952

0.94

0.28

1.4

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

316

1.11

0.27

1.3

52.43

39.43

1.52

227

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

216

1.14

0.27

1.4

1.2

0.62

51.91

mg/l

1.16

154

(3026726) Creatinine [Moles/volume] in Specimen

1.22

0.26

1.9

2.1

771.25

255.31

umol/l

0.85

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.35

0.24

1.2

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.24

0.23

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.21

0.23

1.2

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.22

0.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

486

1.07

0.20

2.3

3.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

441

3180

0.97

0.20

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.20

0.19

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.14

0.19

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

249

1694

1.03

0.19

1.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.23

0.18

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.72

0.17

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

117

1.14

0.16

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

107

0.85

0.16

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

151

0.88

0.16

2.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.17

0.15

7.2

10.6

—

(3045788) Cell count panel - Pleural fluid

101

743

0.96

0.15

1.6

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.11

0.15

1.8

1.9

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.09

0.15

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

121

817

1.04

0.15

1.6

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.19

0.13

1.9

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

116

786

1.04

0.13

1.3

6.40

6.14

mmol/l

0.42

105

733

(3001729) Color of Synovial fluid

1.14

0.12

1.3

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

593

0.96

0.11

2.2

2.0

2.14

4.05

ug/l

3.62

544

(3042010) Triglyceride [Moles/volume] in Pleural fluid

147

0.91

0.11

1.1

1.3

2.09

1.84

mmol/l

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.17

0.10

1.4

2.8

0.10

0.11

ug/l

—

(3051101) Glucose [Moles/volume] in Cord blood

168

0.92

0.10

6.4

5.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

861

5997

1.01

0.09

1.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

354

0.95

0.09

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

325

2250

1.02

0.09

3.9

3.5

26.82

40.08

u/ml

1.85

313

2172

(3009871) Measles virus Ab [Titer] in Serum

572

0.97

0.07

1.7

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.05

0.07

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

186

0.94

0.06

1.2

1.3

89.34

267.93

ug/l

0.95

102

(3023199) Leukocytes [#/volume] in Pleural fluid

131

938

0.98

0.06

1.5

3652.84

2357.81

e6/l

0.85

670

(40765096) Chromosome analysis panel by Banding

328

0.96

0.05

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

164

0.94

0.05

1.0

1.2

1.70

1.86

mmol/l

—

(3047189) Immunofixation for 24 hour Urine

427

0.97

0.05

1.8

2.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

0.94

0.05

1.2

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

279

1.03

0.04

1.6

1.3

56.03

61.07

0.35

230

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

161

1.05

0.04

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

133

947

0.99

0.03

2.1

2.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

120

1.05

0.03

1.8

1.9

0.78

0.65

u/field

0.20

120

(3003577) Lead [Moles/volume] in Blood

133

0.95

0.03

1.2

1.6

0.22

0.20

umol/l

—

(40758358) Immune stain study

1.08

0.02

1.0

—

(3025577) Chromium [Mass/volume] in Blood

576

0.99

0.01

2.2

2.1

1.96

2.70

ug/l

1.57

489

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.00

0.00

1.0

1.1

—

(3008607) Semen analysis panel

180

1.02

0.00

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

128

0.99

0.00

1.5

1.3

12.27

15.31

0.25

(3034092) Cytoplasmic Ig cells/100 cells in Blood

190

1.00

0.00

4.1

4.4

—

(40762814) Titanium [Mass/volume] in Blood

179

0.98

0.00

2.7

2.3

4.00

5.21

ug/l

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.02

0.00

2.5

1.8

67.17

63.74

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

241

0.99

0.00

1.6

1.3

3.07

2.31

0.32

204

(3032868) Hemoglobin electrophoresis panel in Blood

157

0.99

0.00

1.5

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

208

1.01

0.00

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

121

847

1.00

0.00

1.6

1.4

37894.24

36027.16

e6/l

0.06

478

(3014891) Appearance of Pleural fluid

1.03

0.00

1.4

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

287

1.00

0.00

2.2

1.7

1.53

4.88

ug/l

1.11

180

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.95

0.00

5.3

5.2

—

(3013862) HLA-DP [Type]

0.90

0.00

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.99

0.00

1.0

1.5

—

510.00

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.90

-0.00

1.0

1.2

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.94

-0.00

1.0

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.94

-0.00

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.95

-0.00

1.7

1.3

—

(46236302) HLA-C [Type] by High resolution typing

0.94

-0.00

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.97

-0.00

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.86

-0.00

1.2

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.88

-0.00

1.6

1.8

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

21.17

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.00

-0.00

3.7

3.5

—

(40760409) HLA-A [Type] by High resolution

0.94

-0.00

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_DEPRESSION_RECURRENT – Recurrent or chronic depression

GWS hits: 33

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Recurrent or chronic depression

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Recurrent or chronic depression (F5_DEPRESSION_RECURRENT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints